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Nature of the Problem/Study 
Prostate cancer is the second most common cancer in men in the United States, with 2.9 million 
men diagnosed with prostate cancer alive today (American Cancer Society, 2017). Given the rate 
of survival and substantial number of men living with prostate cancer, addressing symptoms and 
quality of life in these men is increasingly important. 
Fatigue is reported to be the most distressing side effect of radiation therapy (RT), negatively 
effecting physical function and quality of life (Minton et al., 2013). Finding measures to predict, 
treat and help prevent fatigue can improve long term outcomes in cancer treatment. 
The primary aim of this study is to explore the relationship between physical activity count 
(accelerometry) and perceived fatigue in men with non-metastatic prostate cancer (NMPC) 
receiving EBRT at beginning, midpoint and at end of therapy. 
Methodology 
An observational, correlational study examined the relationship between physical activity level 
(activity counts) and perceived fatigue at three time points, baseline (prior to EBRT), midpoint 
(Day 19-21)  and post-therapy (Day 38-42).  
Free living physical activity was measured with an accelerometer and through daily logs. 
Perceived fatigue was measured with the Functional Assessment of Cancer Therapy-Fatigue 
(FACT-F) at the beginning, midpoint and conclusion of EBRT in men with prostate cancer. 





fatigue scores. Pearson correlation was conducted at the three time points. Linear regression 
analysis investigated if there is a relationship between perceived fatigue scores and activity 
counts at the three time points, while adjusting for baseline score.  
Results 
Physical activity and fatigue were not correlated at any time points, however, total physical 
activity counts were predictive of fatigue at completion of therapy. Lower hemoglobin, baseline 
fatigue and total physical activity counts were predictive of fatigue at completion of therapy. 
These men may have continued their usual activities despite fatigue during therapy or may have 
been sedentary prior to therapy. Physical activity level should be monitored and, as decreasing 








Fatigue is reported to be the most distressing side effect of radiation therapy (RT), 
negatively effecting physical function and quality of life (Minton et al., 2013). It may be related 
to both cancer itself and treatment; and is known to worsen over time during external beam 
radiation therapy (EBRT) (Hsiao, Wang, Kaushal, Chen, & Saligan, 2014). Finding measures to 
predict, treat and prevent fatigue can improve long term outcomes in cancer treatment (e.g., 
identify individuals most likely to experience debilitating fatigue, reduce perceived fatigue, and 
improve quality of life).  
Primary Aim of This Study  
The primary aim of this study is to explore the relationship between physical activity 
(accelerometry) and perceived fatigue in men with non-metastatic prostate cancer (NMPC) 
receiving EBRT at beginning, midpoint and at end of therapy. 
Research Questions 
1. Is there a relationship between physical activity and fatigue at baseline, midpoint and 
conclusion of EBRT therapy? 
2. Does physical activity predict fatigue at midpoint and completion of EBRT? 
 Research Strategy  
Significance 
 Prostate cancer is the second most common cancer and is the third leading cause of death 
in men in the United States. In 2019, 174,650 new cases are estimated to occur, with 31,620 





cases and 10% of cancer-related deaths (Woolen, Holzmeyer, Nesbitt & Siami, 2014).  Despite 
these statistics, 2.9 million men diagnosed with prostate cancer are alive today with a 15-year 
survival rate of 96% (American Cancer Society, 2019).  Given the rate of survival and 
substantial number of men living with prostate cancer, addressing symptoms and quality of life 
in these men is increasingly important. Minton et al. (2013) point out that “as cancer has evolved 
into a chronic disease, the focus has been extended to improving functional status and quality of 
life for survivors” (p. 2125).  
 The general aim of this study is to enhance scientific knowledge in cancer-related fatigue 
by providing insight into physical activity, a key piece of the symptom, which has been largely 
unexplored in men receiving radiation therapy for prostate cancer. Symptom science requires 
synthesis of many factors and understanding the relationship between physical activity and 
fatigue is an important piece of that endeavor. This approach is very much in line with the goals 
of nursing and more specifically the research goals of the National Institute of Nursing Research 
(NINR), which include identifying “biological and behavioral dynamics of symptoms” and 
“clinical factors that can be used to stratify groups of patients with different patterns of 
symptoms” (NINR, 2016, p. 48). 
 Understanding the relationship of physical activity and perceived fatigue may help 
predict fatigue trajectory based on knowledge of baseline physical activity. Predicting those at 
risk for worsening fatigue or worse treatment outcomes could lead to patient education regarding 
when to expect fatigue and possible ways to mitigate it. This study is also expected to contribute 
to the body of knowledge used to inform future intervention studies evaluating various types of 
physical activities and timing relative to treatment outcomes.  Predictive modeling could be 





physical activity fits with the NIH “precision health” initiative (NINR, 2016) and may improve 
fatigue levels and quality of life.  Objectively measured physical activity using accelerometers 
needs further investigation, particularly in this population of men receiving EBRT who 
frequently report symptoms of fatigue.  
Theoretical Framework 
 The National Institutes of Health Symptom Science Model (NIH-SSM), serves as the 
theoretical framework for this study (Cashion & Grady, 2015). The model arose from the work 
of the Division of Intramural Research of the National Institutes for Nursing Research (NINR) 
where early connections were being made between symptoms, symptom clusters and emerging 
“omics” methods for biomarker discovery. Biomarkers are molecules that correlate with risk of 
disease or disease severity and possible response to treatment (Hasin, Seldin, & Lusis, 2017).  
“Omics” is a field of study in biological sciences that investigates potential biomarkers of health 
conditions, using genomics, transcriptomics, proteomics, metabolomics and microbiomics 
among others. The NIH-SSM incorporates these innovative “omics” methods with the goal to 
draw on nursing’s “consistent commitment to prevent and eliminate symptoms” (Cashion, Gill, 
Hawes, Henderon, & Saligan, 2016, p. 499), and the nurses’ central role to conduct symptom 
research because of their clinical and research expertise.  
 The basic premise of the NIH-SSM is that complex symptoms can be classified into 
various phenotypes, which then have associated biomarkers and which can lead to clinical 
applications. The model is represented as a circle rather than a linear trajectory to demonstrate 







Figure 1: The National Institutes of Health-Symptom Science Model (NIH-SSM). (From 
Cashion, Gill, Hawes, Henderson & Saligan (2016). Used with permission.) 
 
The NIH-SSM, explained in detail above, represents a paradigm shift in nursing research, 
as it is based on the work done at the NINR intramural program to “use emerging ‘omics’ 
methods to study symptoms experienced by the individual” (Cashion et al., 2016, p. 500). This 
dissertation study, conducted at the NINR in collaboration with some of the original authors, can 
serve as an important step to advance further research. While not moving on to the “omics” 
portion of the model, the focus on real-world, observable characteristics emphasizes the 
importance of developing clear characterization of symptom phenotypes prior to and alongside 
“omics” research investigating biomarkers. 
The NIH-SSM has also been applied to cancer-related fatigue as depicted below. Physical 
activity may be a factor in high versus low fatigue phenotypes and is a potential behavioral 






Figure 2: NIH-SSM specific to Cancer-Related Fatigue.  
(From Cashion et al., 2016. Used with permission.) 
 
Innovation.  
While the use of accelerometry or the use of fatigue scales, such as the Functional 
Assessment of Cancer Therapy-Fatigue (FACT-F) are not new or novel, the use of these two 
validated tools together in this population has seldom occurred. Many studies have relied on self-
report alone for one or both measures. Accelerometry data in this population will be very useful 
in determining cut-points for determining sedentary activity in cancer fatigue, which will be 
useful in guiding further research. 
The NIH-SSM may come to be viewed as a new paradigm for nursing research. Reynolds 
(2007) describes four criteria that determine a paradigm, each being demonstrated in this model. 
The first characteristic of a paradigm is “a unique description of the phenomena” (p. 25). This 





phenotypes from multiple angles and how those relate to biomarkers. This relationship leads to 
Reynolds’ second characteristic, new research strategies, namely the development of symptom 
phenotypes and then the association with biomarkers. A new paradigm should generate new 
research questions, such as the one posed in this study, born from the focus on symptom 
description. Further research questions will certainly be generated searching to link established 
fatigue phenotypes with biomarkers. Finally, Reynolds (2007) requires a paradigm to “explain 
events previously unexplained” (p. 25).  This model clearly provides a path for new explanations 
since symptoms to date have not been examined closely in relation to other symptom clusters or 
biomarkers. 
 The NIH-SSM is composed of definitional, existence and associative statements. 
Symptoms are defined “as the self-reported perception of an individual’s experience of disease 
or physical disturbance and can include experiences such as fatigue, pain and cognitive 
dysfunction” (Cashion et al., 2016, p. 500). Another key definitional statement in the model is 
symptom clustering, which “occurs when patients experience multiple symptoms concurrently” 
(p. 500).  The model relies on the existence statement that phenotypes for various symptoms do 
exist, based on “observable characteristics and traits” from “behavioral, biological and clinical” 
data (p. 500). This fits with Reynolds’ (2007) description of existence statements as “providing 
typology, a classification of objects or phenomena” (p. 69). For example, patients can be 
classified into high fatigue and low fatigue groups with associated behaviors and biomarkers 
(Feng, Suy, Collins & Saligan, 2017). While causation is difficult to prove, the model is based on 
the associative statement that symptoms are the most common motivator for seeking health care 





symptoms have particular phenotypes. Phenotypes are associated with specific biomarkers, and 
biomarkers may lead to clinical applications (Cashion et al., 2016).  
Assumptions. 
Associative statement #1. The primary associative statement addressed in this study is 
that a complex symptom (fatigue) has a clinically relevant phenotype, which can be refined over 
time, through further research. Although assumptions for the NIH-SSM are not overtly stated, 
assumptions for the Symptom Management Model (Dodd et al., 2001), which influenced the 
development of the NIH-SSM are very applicable to the association of complex symptoms with 
phenotypes. The first assumption is that symptoms are based on the perception of the individual 
and the self-reporting of that individual. This assumption is important because while seemingly 
obvious that symptoms are individualized, the reporting of those symptoms could vary 
dramatically from the actual perception of the symptom. 
 The next assumption is that symptoms are dynamic, depending on the individual and 
outcomes related to the person, health, and environment (Dodd et al., 2001). This assumption 
holds true and may be the most important because of the multifactorial nature of symptoms. 
Biological, social, emotional, geographical, and other considerations all contribute to the 
development, perception, and expression of symptoms. 
 The associative statement linking complex symptoms to phenotype is appropriate and 
relevant to direct the development of nursing knowledge. The authors of the NIH-SSM point out 
that nurses have unique knowledge and skills to address symptoms because of their close 
involvement with the patient as well as an understanding of biological mechanisms (Cashion & 
Grady, 2015). Nurses are most likely to see how an individual patient expresses symptoms. 





parallels the goals of the NIH Precision Medicine Initiative to develop a personalized approach 
to advancing science and improving the lives of patients. While “omics” play an increasing role 
in nursing research (Wright, Ralph, Ohm & Anderson, 2013), this focus on symptoms and their 
characteristics point out the importance of the person and what is observed outwardly. This helps 
maintain the focus of research, keeping it relevant and in the realm of nursing. 
 Associative statement # 2. The second relevant associative statement is that accurately 
identified phenotypes lead to biomarker discovery (Cashion & Grady, 2015). Several key 
assumptions from Dodd et al. (2001) also apply here. The first assumption is that symptoms may 
not yet be experienced but can be predicted, and thus interventions planned. Predicting 
symptoms is a major focus of biomarker discovery, particularly in the cancer fatigue population. 
With strong phenotype-biomarker association, fatigue can be predicted, patients educated on its 
likelihood, and therapeutic interventions planned. 
 A final assumption is that biomarkers can be identified and will be useful in the future. 
While biomarker research is increasing dramatically and becoming more accessible to a variety 
of researchers (Anderson, 2015), the sheer number of possibilities is daunting. Years of research 
may go into the investigation of biomarkers that ultimately have little clinical utility. The 
extreme volume of possibilities and data available in this era of “big data” warrant consideration 
and prioritization of phenotype-biomarker combinations that show promise.  
 Implications of the model. The phenotype-biomarker connection has clear implications 
for directing nursing research. In fact, it may appear that it is the primary driver of research 
promoted by the NINR as it has been a major focus of the NINR research agenda and 
educational offerings (Cashion, 2017). The focus on the phenotype-biomarker association has 





including nursing, the National Cancer Institute (Hsiao et al., 2014), mental health (Saligan, 
Luckenbaugh, Slonena, Machado-Vieira & Zarate, 2016), and others (Cashion et al., 2016). 
Gaining an understanding of physical activity as it relates to fatigue may aid in developing an 
accurate phenotype, the visible characteristics of interaction between the genotype, and the 
environment. The scope of this dissertation study may be a first step to advancing phenotype and 
biomarker discovery.  The results will be interfaced with the phenotype and biomarker research 
within the larger NIH study protocol on this population of men.    
 One criticism of the NIH-SSM and the phenotype-biomarker connection in particular is 
that the arrow connecting the two does not go in both directions. Phenotype development is 
necessary for biomarker discovery, but the model does not focus on returning to phenotype 
refinement, based on biomarkers. The model is circular, but interventions lie between biomarkers 
and a return to phenotypes. One does not need to wait for interventions to re-examine 
phenotypes, based on biomarkers. Feng, Dickinson, Kline and Saligan (2016) found that 
biomarkers differed greatly, based on methods used to phenotype fatigue, thus the idea of 
phenotype should be revisited, based on biomarker evidence.  While the model is new, there 
seem to be fewer studies on interventions, which if following the model exclusively could result 
in a bottleneck for further discovery.  
Delimitations 
 This study examines data that has been collected as part of an ongoing NINR study since 
2014. Data was collected until December 2018. Participants were men receiving EBRT for 
NMPC at the NIH Clinical Center, Bethesda, Maryland and were also enrolled in one treatment 
study with the National Cancer Institute. Fatigue level, measured with FACT-F, and physical 





post-EBRT. Specific exclusion criteria and operational definitions are discussed in detail in 
chapter three. 
The Researcher 
 While enrolled in the PhD program at the University of North Dakota, the researcher 
became affiliated with the NINR as a special volunteer with the Symptoms Biology Unit, part of 
the Symptom Management Branch of the NINR Division of Intramural Research. The current 
focus of the Symptoms Biology Unit is understanding the biobehavioral correlates of Cancer-
Related Fatigue. A summer internship and research practicums were completed under Dr. Leorey 
Saligan, one of NINR’s tenure track investigators. The researcher was mentored and participated 
in many facets of the work of the Symptoms Biology Unit. These areas included conducting data 
collection with the research nurse, orientation to working with samples in the laboratory, 
observing and monitoring patients during exercise interventions, using study forms to gather 
data, reviewing procedures for storing of data, and reviewing data from physical activity 
monitors and logs. Attendance at unit meetings and other activities at NIH provided mentoring 
and networking with members of the Symptoms Biology Unit, which includes interprofessional 
doctorally-prepared researchers in laboratory, clinical, and animal research areas. Team members 
cited in this dissertation include L. Saligan, R. Feng, B. Wolff, K. Dickinson (Filler) and A. 
Ross. The researcher has attended numerous lectures and discussions offered on the NIH 
campus. The researcher also completed required NIH trainings in classroom and online formats 
including modules on Human Subjects Research, Laboratory Safety, Genetic Research, Social 
and Behavioral Research, and Shipping of Biological Materials. 
In collaboration with mentors in the Symptoms Biology Unit, this researcher began a 





cancer fatigue study. A poster presentation with initial data was made at the NIH in August 2016. 
In early 2017, additional data was gathered and refined with further findings presented at the 
Midwest Nursing Research Society conference in March of 2017. The researcher has written 
multiple academic papers on the topic of cancer-related fatigue in men with prostate cancer 
throughout the PhD program at the University of North Dakota and was a co-author of a 
publication with the NINR team (Feng, Fuss, Dickinson, Ross & Saligan, 2019). 
Conclusion 
 This chapter has described the problem of cancer-related fatigue, how it may affect men 
with prostate cancer, and outlines the importance of examining physical activity in this 
population. The purpose of the study, primary aim. and research questions were described. The 
theoretical framework used, the NIH-SSM, was discussed in reference to this particular research 
problem. Assumptions and delimitations of the study were explained. An in-depth literature 
review is provided in Chapter Two and the specific methodology used in this study is explained 






REVIEW OF THE LITERATURE 
 Cancer-related fatigue is the longest lasting and most disruptive symptom in men with 
prostate cancer (Husson et al., 2015; Weis, 2011) with some men noting fatigue more than one 
year after treatment (Feng, Wolff, Lukkahatai, Espina & Saligan, 2016).  Cancer-related fatigue 
is defined as “a distressing, persistent, subjective sense of physical, emotional and/or cognitive 
tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent 
activity and interferes with usual functioning” (National Comprehensive Cancer Network, 2017, 
p. PFT 1).  
 Fatigue occurs mostly with treatment but can persist and prevent men from working or 
resuming normal activity for up to a year (National Comprehensive Cancer Care Network, 
2017). Persistent fatigue was present at one year in 22% of cancer survivors in a group with 
mixed cancers (Goedendorp, Gielissen, Verhagen & Bleijenberg, 2013). Specifically, radiation 
therapy (RT) is a significant cause of fatigue with the incidence of fatigue related to RT reported 
to affect 71% (Langston, Armes, Levy, Tidey, & Ream, 2013), up to approximately 80% of 
patients (Miaskowki et al., 2011). Approximately a third of patients will have fatigue one year 
post treatment, ranging from 24% (Langston et al., 2013), up to 41% (Feng, Wolff, et al., 2016).  
These late onset symptoms are postulated to occur due to release of reactive oxygen species and 
persistent inflammation induced by radiation and can be present even at two years post RT 






Mechanisms of Fatigue 
 Physiologic pathways leading to cancer-related fatigue continue to be explored in the 
literature. The National Comprehensive Cancer Network (NCCN) (2017) suggests multiple 
mechanisms causing cancer-related fatigue including “pro-inflammatory cytokines, 
hypothalamic-pituitary-adrenal (HPA) axis dysregulation, circadian rhythm desynchronization, 
skeletal muscle wasting, and genetic dysregulation” (p. MS-2) but notes limited evidence for 
these various mechanisms. In addition to these factors, an expert panel review cited 
metabolic/endocrine disruption and abnormalities of neuromuscular function (Saligan et al., 
2015).  There may also be a “deficient adaptive response to insults from cancer therapies” 
(Gonzalez, Abbas-Aghababazadeh, Fridley, Ghansah & Saligan, 2018, p. 3). Production of 
reactive oxygen species was associated with fatigue developed during RT (Hsiao, Wang, 
Kaushal, Chen & Saligan, 2014). Sestrins, genes activated by stress, may also play a role, as 
downregulation of a particular sestrin was recently associated with worsening of fatigue in men 
with prostate cancer treated with RT. This may have therapeutic implications for antioxidant 
supplementation or exercise (Gonzalez et al., 2018), given that exercise was found to positively 
effect sestrin regulation in a mouse model (Lenhare et al., 2017). A specific genomic profile and 
phenotype may also be responsible for the experience of fatigue (Feng et al. 2015).  
 A “vicious cycle” of fatigue has been noted, with fatigue leading to reduced physical 
activity, which then worsens fatigue, leading to further deconditioning and increased morbidity 
and mortality (Nail, 2002; Siegel, Lekas & Maheshwari, 2012; Vermaete, Wolter, Veerhoef & 
Gosselink, 2014). An increase in sedentary behavior may worsen fatigue and functional decline 
from cancer treatments (Phillips et al., 2015). Sedentary behavior, measured as time with counts 





other factors (Phillips, Lloyd, Awick & McAuley, 2016).  Variations in physical activity have 
been associated with cancer-related fatigue (Yennurajalingam et al., 2016). Physical inactivity 
has known consequences including decreased quality of life and physical functioning among 
cancer survivors (Blair, Robien, Inoue-Choi, Rahn & Lazovich, 2016; Vallance et al., 2014) and 
is associated with increased mortality (Canniotto et al., 2016;  Krane et al., 2018) 
Consequences of Fatigue 
 Persistent fatigue can have a profound impact on function and quality of life, possibly 
even years after cancer treatment (Goedendorp et al., 2013). Consequences include interference 
with ability to work, economic hardships, unemployment, increased hospitalization, disruption in 
treatment, and decreased survival (Larkin, Lopez & Aromataris, 2014; Gonzalez et al., 2018). 
Personal consequences can also affect work, family and social lives, which can be “accompanied 
by guilt, anger, boredom and loss of self-esteem” (Larkin et al., 2014, p. 550).  
It is important to understand subsets of physical activities, including exercise, Activities 
of Daily Living (ADLs), Instrumental Activities of Daily living (IADLS), other “lifestyle 
activities,” and how they may affect fatigue and change over time as a result of fatigue. Table 1 
defines terms of varied activity.  
“Lifestyle activities,” activities carried out during the normal course of a day, may differ 
among individuals and groups and may not be accurately captured through self-report. Some 
groups may be more active based on geography, occupation, and other factors. Objective 
measurement of physical activity would be useful in detecting these differences and quantifying 







Table 1. Variations in Activity 
Term Definition 
Physical activity Bodily movement produced by the 
contraction of skeletal muscle that increases 
energy expenditure above a basal level. It can 
be categorized according to mode, intensity 
and purpose (Physical Activity Guidelines 
Advisory Committee, 2008). 
Activities of Daily Living (ADLs) "Activities required for everyday living 
including eating, bathing, toileting, dressing, 
getting into or out of bed or a chair, and basic 
mobility” (Physical Activity Guidelines 
Advisory Committee, 2008, p. C-2). 
Instrumental Activities of Daily Living 
(IADL) 
“Activities related to independent living 
including preparing meals, managing money, 
shopping for groceries or personal items, 
performing housework and using a telephone” 
(Physical Activity Guidelines Advisory 
Committee, 2008, p. C-2) 
Lifestyle activities “Actions that one carries out in the course of 
one’s daily life that can contribute to a 
sizeable energy expenditure such as taking the 
stairs instead of the elevator, walking to do 
errands instead of driving, getting off the bus 
one stop earlier or parking further away than 
usual” (Physical Activity Guidelines 
Advisory Committee, 2008, p. C-2). 
Exercise “A sub-category of physical activity that is 
planned, structured and repetitive and 
purposive in the sense that the improvement 
or maintenance of one or more components of 
physical fitness is the objective (Physical 
Activity Guidelines Advisory Committee, 
2008 p. C-1) 
 
Exercise as Intervention for CRF 
While this study is not an intervention study, it is important to be aware of the current 
state of the science regarding interventions for CRF. Monitoring for CRF is recommended by the 





measured in a free-living setting differs from structured exercise, but increased physical exercise 
outside of an exercise program may have similar benefits. Other interventions recommended for 
fatigue include energy conservation, physical activity, psychosocial support, sleep, and 
nutritional interventions. Pharmacologic interventions are limited but may include treating pain 
and the possible use of methylphenidate to relieve fatigue. While sleep and depression are often 
associated with fatigue, the use of antidepressants or medications to aid sleep are not currently 
recommended for fatigue. Pain, anemia, depression, sleep, and nutritional problems may be 
treated as necessary (NCCN, 2017).  
 Mustian and colleagues (2017) found that exercise and psychological interventions, 
which included group or individual therapy and cognitive behavioral therapy among others, 
together and individually improved CRF, where pharmacologic interventions did not, thus 
recommending exercise and psychological intervention as first line treatment for CRF. The 
Oncology Nursing Society has recommended physical activity to help reduce CRF as a priority 
(Choosing Wisely, 2015; Huether, Abbott, Cullen, Cullen, & Gaarde, 2016). 
 Improvement in CRF with exercise has been noted in women (Cho, Dodd, Cooper, & 
Miaskowski, 2012; Spahn et al., 2013) and in mixed gender groups (Cramp & Byron-Daniels, 
2012; Huether et al., 2016; Kummer, Catuogno, Persues, Bloch & Baumann, 2013). In other 
studies, exercise did not affect CRF (Coleman et al., 2012; Ergun, Eyigor, Karaca, Kisim & 
Uslu, 2013). In a systematic review, Cramp and Byron-Daniel (2012) found aerobic exercise, but 
not resistance or other exercise, reduced CRF in breast and prostate cancers, while Keough and 
Macleod’s review (2012) found reduction in CRF with both aerobic and resistance exercises. In 
two reviews involving participants with multiple cancer types, Mishra and colleagues (2014, 





(HRQOL) from exercise interventions, leading them to recommend exercise as part of the 
treatment plan for those scheduled for or actively receiving cancer treatment.   
Exercise in prostate cancer. The majority of studies conducted have been in women 
with breast cancer or mixed gender and mixed cancer groups with relatively few in men with 
prostate cancer and RT. Supervised exercise programs have shown benefits in men with prostate 
cancer (Hojan, Kwiatkowska-Borowczyk, Leporowska & Milecki, 2016; Ross, Dickinson, 
Nguyen & Saligan, 2017). Moderate intensity exercise was found to improve fatigue, increase 
functional capacity and decrease pro-inflammatory cytokines in men with prostate cancer (Hojan 
et al., 2017). Resistance and aerobic exercises both decreased fatigue initially with longer term 
anti-fatigue effects seen from resistance exercise (Segal et al., 2009). A structured aerobic 
exercise program in men receiving RT for prostate cancer showed no worsening of fatigue 
during treatment, improved depressive symptoms, mitigation of urinary symptoms, and 
improved sleep when compared to a group with no exercise (Ross, Nguyen, Dickinson & 
Saligan, 2017). 
Physical Activity in Cancer Related Fatigue 
While exercise interventions have been examined as a treatment for CRF, there is a 
difference between structured exercise and everyday level of physical activity (Wolvers et al., 
2018). Studies examining everyday activity, which include lifestyle activities, are not as 
prevalent as those examining exercise. Many studies do not use objective measures of physical 
activity or use specific fatigue scales when investigating for correlations between fatigue and 
physical activity. Many studies on physical activity in CRF were either not conducted in the U.S. 





In patients undergoing chemotherapy, higher symptom burden was associated with less 
objectively measured overall physical activity and increased sedentary time (Low et al., 2017). 
Increasing the amount of time spent in moderate to vigorous physical activity (MVPA) is 
associated with a decrease in fatigue in several studies carried out predominantly in women with 
breast cancer (Ehlers et al., 2017; Wolvers et al., 2018), colon cancer (Vallance Terry, Courneya, 
& Lynch, 2014), and lymphoma (Vermaete et al., 2014). A study in cancer survivors found no 
difference in mean daily physical activity between cancer survivors and participants in the 
control group but did find physical activity decreasing significantly as the day went on and an 
association of decreased physical activity with fatigue (Timmerman, Weering, Tönis, Hermens  
& Vollenbroek-Hutten, 2015).  
In the Netherlands, Wolvers et al. (2018) explored physical activity, using accelerometry 
and fatigue in patients with mixed types of cancer with the majority of the participants being 
women with breast cancer. They found physical inactivity to be both due to and a cause of 
fatigue. In their study, active participants had less improvement in fatigue with increased 
physical activity when compared to sedentary or average activity groups, leading the authors to 
suggest that these patients may actually benefit from a decrease in physical activity with a 
decrease in overall sedentary time by making changes to their daily routine. Use of objective 
measures, as specified in the Wolvers et al. (2018) study, is warranted to examine the potential 
associations between physical activity and fatigue in a variety of populations, including men in 
the U.S. with prostate cancer. 
Lower levels of physical activity prior to therapy were associated with fatigue at baseline 
and post therapy in breast cancer, using a self-report of physical activity (Goedendorp, Gielissen, 





Self-reported physical activity level was not associated with level of perceived fatigue before or 
after chemotherapy in another study (Neil, Gotay & Campbell, 2014). Research employing 
objective measurement of physical activity in diverse groups of cancers is needed. 
Decreased physical activity, measured with accelerometers, was associated with 
increased fatigue in patients with breast cancer receiving chemotherapy (Jim et al., 2011) and 
after completion of treatment (Minton & Stone, 2012). Cancer patients with fatigue specifically 
demonstrated less total physical activity measured in cpm by accelerometry and less time spent 
in light physical activity than a non-fatigued group (Minton & Stone, 2012), which underlines 
the importance in focusing on routine daily physical activity, not solely on structured exercise. 
Physical Activity in Prostate Cancer 
 Physical activity research specific to prostate cancer is sparse in comparison with breast 
cancer and other cancers. Gaskin and colleagues (2016) found improvement in quality of life 
scales with increased physical activity and decreased sedentary time which they deemed 
clinically significant, while not statistically significant, in a group of men with prostate cancer. 
Goedendorp et al. (2013) conducted a study in a variety of cancers but found that prostate cancer 
participants had less persistent fatigue than other participants. Research focusing on physical 
activity specific to men receiving RT for prostate cancer is even more rare. Bohn and colleagues 
(2019) found no difference in self-reported physical activity between various prostate cancer 
therapies. In a small study, Drouin et al. (2012), measured physical activity and fatigue at weeks 
1, 4 and 6 of therapy, finding that higher levels of physical activity prior to RT may lead to 







Use of Objective Measures of Physical Activity 
 Physical activity can be measured by duration, frequency and intensity for a period of 
time and can be classified as types of behavior, such as activity, sedentary time and sleep 
(Ainsworth, Cahalin, Buman & Ross, 2015). Self-reporting of activity levels is frequently used 
in physical activity research; however, self-reported physical activity was not consistently found 
to correlate with objective measures such as overall accelerometry physical activity counts. Self-
reports of physical activity correlated with high intensity physical activity but not with light to 
moderate intensity physical activities (Ainsworth et al., 2015; Timmerman et al., 2015). The 
activities carried out by a fatigued population are likely to be light to moderate; however, 
accelerometers are known to have difficulty in accurately measuring these lower levels of 
physical activity (Ainsworth et al., 2015). Commonly used categories for physical activity based 
on accelerometry are sedentary, light, moderate and vigorous activity (Ainsworth et al., 2015). 
Specific cpm values used to determine the categories vary somewhat between devices and 
populations. Cut points for the Actical accelerometer in adults as reported by Colley and 
Tremblay (2011) are listed below in Table 2. 
Table 2. Actical accelerometer cut-points in adults 
 (Colley &Tremblay, 2011) 
Sedentary < 100 cpm   
Light > 100 cpm-1534 cpm 
Moderate 1535 cpm – 3959 cpm 
Vigorous > 3960 cpm 
 
Barriers to Physical Activity 
 While increased physical activity, either through structured exercise programs or in daily 
activities has shown to be beneficial in reducing fatigue, barriers exist to increasing physical 





structured exercise (Larkin et al., 2014), which again underscores the importance of increasing 
physical activity throughout the day to improve treatment outcomes, including fatigue, sleep and 
quality of life, among others. Men, in particular, may not engage in additional physical activity 
due to a perception of meeting their physical activity needs through work (Drummond, Elliott, 
Drummond & Lewis, 2017).  Men who were active prior to diagnosis reported decreasing their 
physical activity after a diagnosis of prostate cancer due to fatigue related to the disruption in 
routine activities caused by diagnosis and treatment and not being sure if they should exercise 
following their diagnosis (Sheil, Guinan, Hevey & Hussey, 2017). The men also reported 
declining mood and confidence related to the effects of androgen deprivation therapy and urinary 
incontinence as barriers to physical activity. Weather, time of year and availability of facilities 
for physical activity are also factors that may affect men’s decision to engage in physical activity 
beyond those required as part of their daily routine (Sheil, Guinan, Hevey & Hussey, 2017).  
Barriers to Symptom Reporting 
 Fatigue is a subjective experience, and therefore the individual’s self-report of that 
experience is important to capture. Men, in particular, may have barriers to reporting fatigue, 
which could affect research in this area. Based on previous research, money, deprivation for 
benefit of family, and seeing healthy behaviors or seeking help as a feminine trait have been 
barriers to seeking care for men (Courtenay, 2000; Drummond et al., 2017). It is possible that 
similar barriers may exist for fatigue reporting. Men may be less likely to share feelings about 
symptoms, with a possible link between sexual functioning and masculinity in relation to 
feelings of fatigue as well as genitourinary consequences of prostate cancer and its treatment 
(Jonsson, Aus & Bertero, 2009). There may be a fear of appearing “weak and vulnerable” 





higher fatigue (Luo et al., 2016). Lack of symptom reporting may also fit in with the importance 
of work to men in jobs requiring physical labor who live in rural areas (Long & Weinert, 1999).  
 Men may be less likely to report symptoms than women. In comparing women with 
breast cancer and men with prostate cancer, Garrett et al. (2011) found that women reported 
increased fatigue and sleep disturbance compared to men; however, sleep measured with 
actigraphy showed more sleep disruption in men. This could reflect a broader issue of symptom 
perception or reporting in men. 
Effect of Age on Fatigue 
 
 The effect of age on fatigue is less clear than it may seem. Saligan et al. (2015) conducted 
a review of the literature and found conflicting results. Hamre et al. (2013) found an increase in 
fatigue with age in a cross-sectional study of childhood leukemia survivors. Fagundes et al. 
(2011) found no significant difference in fatigue based on age in breast cancer patients; whereas, 
Banthia, Malcarne, Ko, Varnia and Sadler (2009) and Ehlers et al. (2017) found increased fatigue 
in younger breast cancer patients. Younger age was also found to be a factor leading to increased 
fatigue in men with prostate cancer undergoing RT in a descriptive, longitudinal study 
(Miaskowski et al., 2008).  Poirier (2006) also found younger age is associated with increased 
fatigue in a descriptive study of radiation oncology patients and suggested that greater time 
demands for younger patients may contribute to an increased sensation of fatigue. Siegel et al. 
(2012) conducted a qualitative descriptive study, discussing age as a factor that was not often 
isolated, with previous research yielded differing findings. 
Age may have a variable effect on physical activity, depending on the overall health of 
the participant. Older men with prostate cancer were less likely to exercise (Bohn, Fossa, Wisloff 





2017). Age was not associated with physical activity level in cancer survivors (Dennett, Peiris, 
Shields & Prendergast,2018); however, older individuals in the general population were more 
likely to adhere to physical activity guidelines for cancer prevention (Kohler et al., 2017).  
Body Mass Index (BMI), Anemia, and Sleep 
 This study examined age, Body Mass Index (BMI), hemoglobin level, and sleep 
(assessed with the PROMIS-Sleep Disturbance scale). These variables have been used as co-
variates in studies closely related to the ongoing NINR protocol (Feng et al., 2018; Feng, Espina 
& Saligan, 2015; Feng et al., 2015). 
BMI is frequently controlled for in CRF studies and failure to do so could lead to 
erroneous results (Gerber, 2017). Decreased BMI was associated with increased physical activity 
in breast cancer, but no direct relationship was found between BMI and vitality, used as a 
measure of fatigue (Kenzik et al., 2018). Conversely, Schmidt and colleagues (2015) found that 
lower levels of physical activity and increased BMI were associated with long term CRF. In 
colorectal cancer survivors, BMI was associated with fatigue and physical, emotional and role 
functioning (Vissers et al., 2017). Recent studies found no difference in age or BMI between 
fatigued and non-fatigued groups of men one year after EBRT for non-metastatic prostate cancer 
(Feng et al., 2018), and in stable versus increased fatigue groups (Feng, Espina & Saligan, 2018).  
Anemia was associated with radiation-induced fatigue in a literature review by Hsiao, 
Daly and Saligan (2016). Compared to the general population, those with cancer showed greater 
fatigue and cancer patients with anemia displayed more fatigue than those without anemia (Cella 
at al., 2002b). Feng et al. (2015) found that a reduction in a composite variable including red 





EBRT for prostate cancer. In patients with metastatic disease, anemia due to cancer metastasis 
may be one pathway to increased fatigue (American Cancer Society, 2018).  
Sleep disruption has been found to co-occur with fatigue in cancer and cancer treatment. 
During chemotherapy, fatigue and insomnia were correlated (Redeker, Lev & Ruggiero, 2000). 
In breast cancer, fatigue was related to increased number of nighttime awakenings (Berger et al., 
2010). Increased fatigue in women with gynecologic cancer was associated with minutes awake 
at night and regularity of sleep and physical activity patterns (Jim et al., 2011). In men receiving 
EBRT for prostate cancer, disrupted sleep as a result of urinary symptoms is also associated with 
fatigue (Feng, Fuss, Dickinson, Ross & Saligan, 2019). 
Strategies for data collection and analysis of anemia, BMI and sleep are detailed in 
Chapter 3. 
Fatigue Trajectory Over Time 
 Reports on the trajectory or change in fatigue over time in patients receiving RT for 
prostate cancer have varied (Knapp et al., 2012). A longitudinal study found increased fatigue 
during the course of RT, with a return to baseline following treatment (Geinitz et al., 2010). This 
lack of energy and drowsiness “steadily improved over the course of the cancer treatment” 
(Knapp et al., 2012, p. 503). Persistent elevation of fatigue symptoms has been observed twelve 
months or later following RT in another longitudinal study (Monga, Kerrigan, Thornby, Monga 
& Zimmermann, 2005). However, a large amount of interindividual variability in fatigue 
symptoms was observed over the course of RT for prostate cancer (Miaskowski et al., 2008).   
 While noting the general trajectory of improving fatigue over time, Poirier (2006) noticed 
an interesting variation with 35% of study participants reporting a dramatic increase in fatigue 





suggests that a “let down” (p. 598) may occur at the conclusion of treatment when the patient is 
no longer receiving the support of nurses and radiation therapists, potentially affecting fatigue 
scores. While not recording fatigue levels beyond completion of therapy, Hsiao et al., (2014) 
found greater variation in fatigue among participants at completion of RT with some reporting 
very severe fatigue. 
 An increase in fatigue following therapy has also been reported. Monga et al. (2005) 
found fatigue scores were highest one year following therapy. They reported fatigue scores 
above pre-treatment baseline at the mid-therapy mark, a further increase at completion of 
therapy, followed by a slight decrease during the 4-8 weeks post therapy. The worst fatigue was 
1-year post-treatment with 40% of participants reporting fatigue at that point. In a 5-year 
prospective study, Fransson (2010) found the highest level of fatigue at the 5-year mark in 
prostate cancer patients, with 66% of participants reporting fatigue at that time. 
Cancer-Related Fatigue Research at NINR 
 The National Institute for Nursing Research (NINR), the location of the study, has 
prioritized cancer-related fatigue as a key area of research focus (Cashion, Gill, Hawes, 
Henderson & Saligan, 2016). NIH recommends examining the problem from a variety of angles. 
In previous investigations from the parent NINR study on men receiving RT for prostate cancer, 
scientists at NINR found no fatigue at baseline. However, fatigue increased during RT and was 
decreasing at completion, but it persisted in a subset of patients for up to two years. This 
trajectory of fatigue correlated with unique biomarkers for up to the two-year mark (Feng et al., 
2017; Feng, Wolff et al., 2016; Filler et al., 2016; Hsiao, Reddy, Chen & Saligan, 2015). Clinical 
predictors of fatigue were identified, including decreased red blood cells and the use of androgen 





was also identified. Anorexia, urinary, depressive and cognitive symptoms all accompanied 
fatigue in men treated with RT for prostate cancer (Feng et al., 2017; Feng, Wolff et al., 2016; 
Lynch Kelly et al., 2016). 
Determining an accurate phenotype of CRF has been examined at NINR. Phenotype is 
defined as “the physical, observable properties and characteristics of an organism arising from 
the interaction of its genetic makeup, or genotype, and the environment” (Funk & Wagnalls New 
World Encyclopedia, 2017).  Various fatigue measurement scales and cut-off points were used to 
determine clinical meaning. The change of ≥ 3 on the Functional Assessment of Cancer Therapy-
Fatigue (FACT-F) delineated the fatigued group from non-fatigued group with associations made 
with biomarkers found in the fatigued group (Feng, Dickinson, Kline & Saligan, 2016).  The 
authors pointed out that further work is needed to characterize the phenotype of CRF. 
Based on findings from previous work, NINR investigators are now examining potential novel 
interventions, including studies on a thyrotropin releasing hormone analogs (Dougherty, Wolff, 
Cullen, Saligan & Gershengorn, 2017) and are conducting an ongoing clinical trial on the 
potential of ketamine to reduce CRF (Cashion, Gill, Hawes, Henderson & Saligan, 2016; 
Saligan, Luckenbauh, Slonena, Machado-Vieira & Zarate, 2016). A trial examining the potential 
effect of a structured exercise program on CRF is also currently underway (Ross et al., 2017).  
Objective Measurement of Physical Activity 
 Use of devices to measure physical activity has increased over the past decade (Troiano, 
McClain, Brychta, & Chen, 2014), and nurses are an important part of that movement, both in 
the clinical setting and in research (Ainsworth & Buchholz, 2017). A variety of populations have 
seen benefits from increased regular daily physical activity, apart from structured exercise 





that directly relate to physical activity, but the relationship between the type, amount, pattern and 
intensity of physical activity and health benefits in various populations is also extremely valuable 
(Dowd et al., 2018).  
Physical activity research has become more affordable and easier to access since the 
beginning of this century (Troiano et al., 2014). Multiple generations of devices have been 
released over the past 30 years (van Hees, Pias, Taherian, Ekelund & Brage, 2010) that have 
decreased in size and cost with increased capabilities (Troiano et al., 2014). The cost of activity 
monitors has decreased significantly, allowing their use on a much larger scale, such as in the 
NHANES study (Troiano et al., 2014)  and the UK Biobank study (Ferguson et al., 2018), but 
this large-scale use is still expensive (Dowd et al., 2018) . 
Activity monitors are increasing in complexity, becoming smaller and less intrusive and 
moving beyond simply examining movement. Sensors are now available in shoes, watches, and 
of course, have become ubiquitous in mobile phones (Altini, Penders, Vullers, & Amft, 2015; 
Redmond et al., 2014) . In conjunction with other devices and data, contextual factors, such as 
location, mode of travel and whom the individual is with can be combined with traditional 
activity monitor data (Gu, 2016). Data from “smart home” systems with environmental sensors, 
cameras and motion detectors may also add important context and it may soon be feasible to 
implant sensors into an individual (Redmond et al., 2014). Methods of interpreting accelerometer 
data have also evolved with a shift from count-based measurements to estimation of energy 
expenditure (EE) and characterization of physical activity into categories such as sedentary, 
light, moderate and vigorous  (Troiano et al., 2014). 
Despite these advances, existing accelerometer data collected with older devices or 





studies may still be using older equipment and methods for several reasons. Research teams are 
compelled to get the most use out of devices, given budgetary constraints, and may need to keep 
methods consistent to allow comparison with data collected earlier in a study (Troiano et al., 
2014). For example, a study that collected data over a period of five years would most likely use 
the same devices and data collection plan for the entire course of the study.  If the accelerometers 
chosen at the outset were not the newest, most expensive model of their time, it is very 
conceivable that the technology and methods applied more resemble those of the early 2000s 
than the present day.     
The use of devices to monitor physical activity, while widespread, does have inherent 
problems that must be considered and accounted for when possible. Many older models only 
store activity “counts” and may have limited battery and storage space, which can result in loss 
of data (van Hees et al., 2010). Since physical activity research focuses on activity in “free 
living” or “real world” rather than controlled laboratory settings, a significant amount of noise 
and artifact can be expected (Haslam, Gordhandas, Ricciardi, Verghese, & Heldt, 2011). Energy 
expenditure, distance walked, and physical activity classification may be estimated incorrectly 
(Dowd et al., 2018). Certain activities are often not detected in proportion to the actual effort 
expended (Altini et al., 2015). Despite these drawbacks, accelerometers have shown a high level 
of validity for measuring activity “counts” (Dowd et al., 2018) and “moderate to strong test-
retest reliability in a free-living environment” (Dowd et al., 2018, p. 20). 
The software that derives the data from the device is extremely important. Each device 
manufacturer creates proprietary software and algorithms to determine “counts” and other 
measurements, such as energy expenditure, which makes comparison across different devices 





differences in the data itself, multiple approaches to interpreting data are used across researchers 
(Biobank, 2016).  
 A variety of factors may cause challenges for researchers who use accelerometers. 
Researchers must invest time in understanding the operation of the monitor (Ward et al., 2005), 
and effort is required for realistic and meaningful data (Gu, 2016).  Physical activity levels vary 
from day to day, and missing data is common (Catellier et al., 2005).  Patient factors, such as 
reactivity or wanting to be a “good patient” as well as non-wear of the device can have 
significant effects (Dowd et al., 2018). Managing the amount of data generated by 
accelerometers can be overwhelming, given multiple days of data collection divided into very 
brief segments (Ward et al., 2005).  
Conclusion 
CRF has many potential implications and is seen as a priority health issue and research 
problem by prominent organizations, such as NCCN and NINR. Research on physical activity in 
men with prostate cancer and how it relates to fatigue is lacking in the literature and should be 
further explored. Chapter 3 describes the methodology for this study, including IRB approval 
and protection of human subjects, selection of instruments, data collection, and data analysis.   
Further details are also outlined in Chapter 3 on the decision trail, followed in the NIH protocol 
for the selection of the type of accelerometer, the determination of what defines a valid day, the 
number of valid days required for the analysis, and the process used for data cleaning and 








 This chapter describes the methodology used in this study. The overall research design 
and strategy, inclusion/exclusion criteria, data collection procedures and protection of human 
subjects are outlined. Statistical methods and data analysis utilized are explained. 
Research Design and Overall Strategy 
Research Design 
An observational, correlational design was utilized to examine the relationship between 
physical activity level (activity county) and perceived fatigue at three time points: baseline (prior 
to EBRT), midpoint (Day 19-21) and post-therapy (Day 38-42). This design was selected 
because it “examines relationships as they exist in a situation” and “facilitates the identification 
of interrelationships” (Grove, Burns & Gray, 2013, p. 225), but does not examine causality (Polit 
& Beck, 2012).  
This study assessed physical activity, measured with an accelerometer and through daily 
logs and perceived fatigue, measured with the FACT-F (Appendix D) at the beginning, midpoint, 
and conclusion of EBRT in men with prostate cancer. Statistical analysis was conducted to 
determine correlations between physical activity count and fatigue scores.  
This study was carried out at the Hatfield Clinical Research Center of the National 
Institutes of Health (NIH), NINR where the author is a PhD student special volunteer, and an 
associate investigator of an existing NIH Institutional Review Board-approved clinical study. 
Archived data from an ongoing NINR protocol make up the majority of data used with data from 





screened by the research team for inclusion criteria and, if met, approached for participation in 
the study. Participants at this site receive 38-42 days of EBRT, based on clinical stage of disease 
(Feng, Fuss, Dickinson, Ross & Saligan, 2019). Previous analysis of the study participants 
enrolled in this study revealed that 62% of subjects are Caucasians and the mean age is 66.1 
years (Feng, Dickinson, et al., 2016). Approximately, 85 patients are treated for prostate cancer 
at this location each year with nearly half of those treated with EBRT. Attrition rates have 
traditionally been low at this site (L. Saligan, personal communication, November 11, 2016). 
 The NINR provides numerous resources to the research team. Collaboration can occur 
across disciplines, including nursing, neuroscience, and bioinformatics. The team also has access 
to technical support and computer resources through NIH. 
Inclusion Criteria 
Inclusion criteria include males 18 years or older diagnosed with non-metastatic prostate 
cancer scheduled to receive EBRT and able to provide written consent. Exclusion criteria include 
major depression, history of bipolar disorder, systemic infections, alcohol abuse/dependence, 
psychosis within the past five years, malignancies other than prostate cancer, uncorrected anemia 
or hypothyroidism, concurrent chemotherapy or significant fatigue, caused by progressive 
disease of another body system. Use of androgen deprivation therapy was evaluated but is not an 
exclusion criterion. These criteria have been used in prior studies at this location (Feng, 
Dickinson, et al., 2016; Hsiao et al., 2014). Each month, approximately 2-4 patients were 
enrolled in the research protocol (L. Saligan, personal communication, November 11, 2016).  A 
member of the research team interviewed potential participants and screened for exclusion 





informed consent, additional information was abstracted from the medical record of the study 
participant by the research team. 
The Hamilton Depression Rating Scale (HAM-D) (Appendix E) was used to screen 
potential participants for depression with a score greater than 17 indicating depression for this 
protocol (Feng, Wolff et al., 2016). Presence of depression would be a confounding variable, 
since it can itself lead to fatigue, so these clients are excluded from the study. The HAM-D 
consists of 21 items and has good internal reliability (a=.81-.98) (Lydiatt, Denman, McNeily, 
Puumula & Burke, 2008). Participants scoring 17 or greater after being enrolled in the study 
would be referred for a mental health consultation as stated in the protocol, however this did not 
occur in the current study. 
Selection of inclusion and exclusion criteria is an important part of designing a research 
study. Too narrow an approach can be problematic, leading to exclusion of particular populations 
from research and potential inability to generalize findings (Grove, Burns & Gray, 2013). In this 
case, however, prostate cancer is a disease, which only affects males, and strict exclusion criteria 
are necessary to prevent confounders, such as other conditions that may lead to fatigue, 
strengthening the possibility that fatigue is related to physical activity. 
Protection of Human Subjects 
As an existing protocol, this study was approved by the NIH Institutional Review Board 
(IRB). The investigator was approved as an Associate Investigator (AI) on this study, 09-NR-
0088. The NIH Primary Investigator (PI), IRB representatives at the University of North Dakota, 
and NIH were consulted to determine if additional IRB approval was necessary. After discussion 





The investigator regularly communicated with the PI and research team to ensure adherence to 
the established protocol. 
 This study represents minimal risk and burden to participants, mostly concerning time 
and effort to complete questionnaires and use the accelerometer. Demographic and questionnaire 
data were collected by the research team during each visit (Appendix B and C).   
Risks to Human Subjects. 
Human subjects’ involvement, characteristics, and design. This study used data from 57 
men enrolled in an ongoing NINR study at the Hatfield Clinical Research Center of the NIH, 
Bethesda, MD. Participants were concurrently recruited for ongoing studies at NIH that have 
been IRB approved (09-NR-0088, 11-NR-0014, PI: L. Saligan). Members of the research team 
attended the National Cancer Institute Prostate Multi-Disciplinary Conference each week to 
identify potential study participants. This recruiting method has been very successful in the past 
(A. Ross, personal communication, February 27, 2018). Participants for this study were 
recruited, using the same IRB-approved protocol mentioned above.  
Once potential participants were identified, the research team reviewed medical records, 
and a screening visit was conducted to determine eligibility. Participants must be able to read and 
understand the written consent form. Informed consent was obtained through a verbal 
clarification of the purpose, procedure, and potential risks of the study. Participants were 
informed that they may withdraw from the study at any time, and it will not affect the course of 
their treatment. If a participant wished not to continue with the study, the participant was not 
contacted for follow up, and his data and existing forms were destroyed. 
Potential risks. The procedures necessary for this study presented minimal risk to 





questionnaire completion, time and effort associated with use of the accelerometer, and the time 
required for clinic visits. Study visits occurred along with treatment visits to reduce burden on 
participants and increase retention. The associated discomforts included the following items: 
a. Medical history and questionnaires: There are no known medical risks related to these 
procedures. Some of the questions may be embarrassing or difficult for the participant to 
answer. 
b. Accelerometer and activity log use: There are no known medical risks related to these 
procedures. Use of accelerometers requires time, may cause discomfort and embarrassment 
(O’Brien et al., 2017).  
Sources of Materials. 
Research materials consisted of demographic, questionnaire, and accelerometer data. 
Demographic and questionnaire data were collected by the research team at each study visit. A 
copy of each questionnaire, including FACT-F, PROMIS-SD and HAM-D are found in the 
Appendix. Participant identities were protected, using identity code numbers, which can only be 
accessed by the principal investigator of the parent study. Questionnaire data was accessed from 
a secure NIH database storage network.  Output from accelerometers was downloaded and stored 
on a secure NINR server, approved for data housing purposes by the NIH Office of Information 
Technology. Participant activity logs were obtained from a secure filing cabinet and scanned to 
the same secure server. 
Data Safety and Monitoring Plan. The office of the NINR Clinical Director and the 
NIH Combined Neuroscience (CNS) IRB oversaw this study, as part of an ongoing protocol. The 
IRB-approved NINR Data and Safety Monitoring Plan (DSMP) specifies evaluation of the 





ensures current state of the science. All reports, produced from the DSMP, were reviewed by the 
CNS IRB. In addition, all NINR studies undergo regularly required quality assurance monitoring 
to ensure that human participants are protected. Minimal risk studies such as this one are 
monitored within 3-6 months of enrolling the first subjects and at least annually after that for the 
length of the study. 
This study used previously collected data from an ongoing trial at this site (NIH Grant # 
09-NR-0088) and planned to recruit additional participants from July 2018 to December 2018. 
Assuming an average of three new participants per month, adding these individuals would have 
yielded 18 new participants; however, enrollment in this protocol slowed dramatically during 
this time. The number of patients treated with EBRT at NIH decreased as did the number of 
patients meeting inclusion criteria. Participants who may have been eligible for this study may 
also have been recruited for other research protocols.  
Power Analysis Power analysis was performed in consultation with the NINR 
statistician, who was available for consultation on this study. There is no available data for 
correlation coefficients between fatigue scores and physical activity. Assuming a medium effect 
size (r=.3) the sample size needed is 112, adjusted for three time point comparisons, with an 
r=.4, a large effect size, requiring a sample size of 61 (X. Zhang, personal communication, 
September 7, 2017). Although a large effect was not expected, data is available for 57 
participants.  This study may serve as a pilot for future studies. 
Methods of Measurement and Instruments 
Data collection included demographic data, Gleason score, presence of androgen 
deprivation therapy (ADT), history of prostatectomy, height, weight, hemoglobin level, objective 





activity with an activity log, and fatigue scores, using the FACT-F. These variables have been 
used in previous studies, using members of this cohort (Feng et al., 2015, Feng et al., 2016). 
Gleason score, ADT, BMI and hemoglobin level are potential confounding variables, therefore, 
were adjusted for in linear regression. 
Participants underwent EBRT at the NIH for non-metastatic prostate cancer. Following 
consent to participate in the study, at baseline (Day 0), the research team gathered demographic 
information and administered the FACT-F. At that time participants were instructed in the use of 
the activity monitor and activity logs. Physical activity was objectively measured with an Actical 
accelerometer (Mini Mitter, Bend, OR) for four consecutive days including three week-days and 
one weekend day in their own environment. Participants also recorded an hourly log of their 
activity for these days, using the NIH activity log form (Appendix A).  At the midpoint of 
therapy (Day 19-21) fatigue scale, activity monitor data and activity logs were again collected. 
This was repeated at the conclusion of EBRT (Day 38-42). This data collection schedule has 
been used previously at this site (Feng, Dickinson, et al., 2016; Hsiao et al., 2014).  





Race White, African American, Asian, Hispanic, Other 
BMI Kg/m2  
Gleason Score 2-10 (extracted from medical record based on scoring 
by pathologist) 
Androgen deprivation therapy Yes/No 
History of prostatectomy Yes/No 





Clinical Characteristics Gleason score, androgen deprivation therapy, and history of 
prostatectomy are collected as part of the ongoing NINR study. These data were recorded but do 
not serve as variables or exclusion criteria in this study. Previous studies at this location have 
included men with and without androgen deprivation therapy and with and without 
prostatectomy as part of the same cohort (Feng et. al, 2016).  
Gleason Score. The Gleason score is assigned by the pathologist examining a prostate 
biopsy sample. Cells are scored 1-5 with 1 being “low grade” tumor cells and 5 “high grade.” 
The most and second most predominant patterns in the biopsy are assigned scores, which are 
totaled, resulting in a score of 2-10. Gleason scores of 2-4 tend to be less aggressive tumors with 
scores of 7-10 being more aggressive (Prostate Cancer Foundation, 2018).  
PROMIS-SD. Sleep disturbance was measured with the Patient Reported Outcomes 
Measurement Information System- Sleep Disturbance (PROMIS-SD) short form. The PROMIS-
SD short form is made up of eight items with good validity (0.83) and internal consistency 
(Cronbach’s alpha >0.90) (Mahieu et al., 2016; Yu et al., 2011,). Several participants were 
missing scores for some items. These values were handled as directed in the PROMIS-SD 
scoring guide. 
FACT-F. The FACT-F has been used for a number of years in cancer settings (Yellen, 
Cella, Webster, Blendowski & Kaplan, 1997) and at this particular location with men treated 
with EBRT for prostate cancer (Feng et al., 2016). The scale is made up of 13 items, scored 0-4, 
with zero being the worst and four the best, with a maximum score of 52. The lower the score, 
the higher the fatigue intensity (Yellen et al., 1997). The FACT-F has strong test-retest reliability 





administration. Psychometric measures, such as the FACT-F, must be assessed for reliability or 
accuracy in measuring what it is designed to measure.  
Cancer patients with fatigue have been differentiated from the general population with a 
FACT-F score of 43 (Cella, Eton, Lai, Peterman & Merkel, 2002) and a change of ≥ 3 has been 
shown to separate fatigued from non-fatigued participants undergoing EBRT for prostate cancer 
(Feng, Dickinson, et al., 2016). This approach allows comparison with baseline fatigue rather 
than with a pre-determined threshold, which determines fatigue.  
 Accelerometer. Accelerometers have been used in multiple cancer studies, including in 
men with prostate cancer (Gaskin et al., 2016). The Actical accelerometer has been used to 
differentiate active from sedentary activity with a cut-off of 100 counts per minute as the 
threshold (Wong, Colley, Gorber & Tramblay, 2011). Its use has been validated in older adults 
(Hooker et al., 2011), but lower cut points may be needed to differentiate sedentary behavior and 
light activity due to the general decrease in activity level in this population. Corbett, Valiani, 
Knaggs and Manini (2016) found that activity counts from accelerometers were associated with 
Metabolic Equivalent of Task (METs), another measure of activity during rapid, but not usual 
activity. The cancer fatigue population may be especially difficult to measure, given the 
possibility of a “flooring effect” in the presence of reduced physical activity level (K. Chen, 
personal communication, July 6, 2016). Actical accelerometer has shown low to moderate 
intraclass correlation (.00-.75) and validity could not be established in a fatigued population with 
multiple sclerosis (Kayes et al., 2009). In a sample of stroke patients, moderate correlations were 
found between Actical accelerometers and a 6-minute walk test (r=0.6-0.73) (Rand, Eng, Tang, 





The research team has encountered and addressed several specific problems with the 
Actical accelerometer. The Actical accelerometers available are a combination of older and 
newer models, but the manufacturer indicates that there is little difference in data provided. The 
research nurse did note difficulty downloading data from newer models because of data speeds 
that were too fast for the available equipment. Battery life in older models is only 10 days and 
could result in lost data due to dead batteries. Participants known to promptly return the 
accelerometer may be given the older models with shorter battery life, if necessary. This would 
allow newer models with longer battery life to be used for new participants (A. Ross, personal 
communication, March 13, 2018). 
Newer accelerometers are now available; however, the research team has access to the 
Actical, and it was used for the earlier participants. At the time the protocol was written and the 
devices purchased, hip worn accelerometers were the standard. Older models, such as the 
Actical, were mainly validated in adult patients worn on the hip versus the wrist (Kamada, 
Shiroma, Harris & Lee, 2017). Hip placed accelerometers had demonstrated much better 
correlation with energy expenditure but over time, wrist worn devices have begun to catch up 
and now are used in large studies, such as the National Health and Nutrition Examination Survey 
(NHANES) (Troiano, McClain, Brytcha & Chen, 2014).  Changing the mode of measurement 
would increase costs and may lead to inconsistencies with data collected previously.  
 Use of these measurements does represent a time commitment on the part of participants. 
The FACT-F consists of 13 items and is completed during scheduled clinic visits, so it does not 
require a great time commitment for the participant. Wearing the activity monitor for four days 





and other activities and then re-applied. The participant is also required to record physical 
activity hourly while awake, which requires effort and significant attention to detail.  
NIH Activity Log. The NIH activity log is used in multiple ongoing studies of cancer 
fatigue (NIH Protocol 09-NR-0088, 11-NR-0014) (See Appendix A). The log contains a line for 
each hour of the day. Participants were instructed to record physical activity each hour and to 
indicate the number of hours spent in a particular activity. Participants were also instructed to 
report non-wear times for activities, such as showering.   
Data Collection and Procedures 
 Participants for this study were recruited through the Hatfield Clinical Research Center 
Radiation Oncology Clinic, NIH, Bethesda, MD. The research team met with potential 
participants and obtained informed consent. The research team met with participants prior to 
scheduled clinic visits at the three time points (baseline, midpoint of therapy, and conclusion of 
therapy). At each visit, the FACT-F questionnaires were explained to the participants by the 
investigator and completed. The participant was provided with an accelerometer and instructed 
in its use, including proper placement, and was instructed in the use of the activity log. 
Instructions for returning the accelerometer and log by mail were given at that time, as well.  
  Potential problems in data collection, using the accelerometers have been identified, 
including failure to complete activity monitoring over the entire four-day period, improperly 
placed monitors, and device failure (Wolvers et al., 2018). Participants may fail to complete all 
survey data for the FACT-F; however, the research team member is present following 
completion and can follow up with the participant prior to the conclusion of the clinic visit. 
Accelerometer data is reviewed for completeness after each recording period, which allows for 





the first data collection period. It is not possible to recover accelerometer data not properly 
recorded at the baseline time point, however.  
 Total physical activity counts were calculated from accelerometer data by taking all valid 
counts and dividing by the number of valid minutes, yielding average counts per minute (cpm). 
Afternoon physical activity was also calculated, using the same method, from 2:00-6:00 pm of 
each valid day. 
Increasing fatigue in the afternoon and evening has been reported in patients treated with 
RT for non-metastatic cancer (Dhruva et al., 2013; Miaskowski & Aouizerat, 2012). This 
phenomenon was also observed in a mouse model of radiation-induced fatigue. The last four 
hours of the active cycle (2am-6am) for mice, that are nocturnal, showed greater fatigue than 
other time periods (Renner et al., 2016). Based on these findings, this study will examine 
physical activity from 2:00 pm-6:00 pm, separately. In addition to average total daily physical 
activity counts, average total counts will be calculated for 2:00 pm – 6:00 pm. This period of 
time is just prior to the wake maintenance zone, a period of increased alertness, several hours 
prior to bedtime (Shekleton et al., 2018). 
Table 4. Variables 
 
Variable How measured When measured 
Total physical activity counts Accelerometer- Total counts per 
day for four consecutive days/ 
total minutes (continuous 
variable) 
Baseline (prior to EBRT) 
Midpoint of EBRT 
Conclusion of EBRT 
Afternoon physical activity 
counts 
Accelerometer- total counts 
from 2:00-6:00 pm on all 
measurement days/total minutes 
(continuous variable) 
Baseline (prior to EBRT) 
Midpoint of EBRT 
Conclusion of EBRT 
Fatigue  FACT-F (continuous variable) Baseline (prior to EBRT) 
Midpoint of EBRT 
Conclusion of EBRT 
Sleep Disturbance PROMIS-SD (short form) 
(continuous variable) 
Baseline (prior to EBRT) 
Midpoint of EBRT 







Researchers are faced with a number of important decisions when working with 
accelerometers and the data they produce. The minimum number of days of accelerometer wear 
required to answer the specific research question (Ferguson et al., 2018), how many hours will 
constitute a “day,” how non-wear will be determined, and the amount of time that the device was 
actually worn (Biobank, 2016; Ward et al., 2005).  The researcher must also decide on 
appropriate methods of measurement, such as activity “counts,” energy expenditure or 
classification of physical activity type (Catellier et al., 2005). Data cleaning methods must be 
employed to find and address missing data (Catellier et al., 2005; Ward et al., 2005), values that 
are excessively high or low, or seem out of context (Biobank, 2016; Ward, 2005). The researcher 
also needs to decide what specifics to report, such as average time worn and data cleaning 
methods so that other researchers may replicate the methods in the future (Ward et al., 2005) 
Definition of non-wear. Numerous methods for defining accelerometer non-wear are 
found in the literature, varying in length of time of no recorded activity and tolerance for single 
values surrounded by inactivity, or “0” readings from the accelerometer. 
One method commonly used is referred to as the Troiano algorithm, adopted by many 
researchers (see Table 5) but originally demonstrated by Troiano and colleagues (2008). This 
approach defines non-wear as 60 minutes or greater of consecutive zero values but allowing for 
up to two minutes of values with counts less than 100. Another commonly used algorithm, (see 
Table 5) developed by Choi and colleagues (2011) defines non-wear as 90 minutes of 0 counts, 
allowing for two minutes of non-zero values if there are 30 minutes of zeroes above and below 





participant log was found to be superior to the Troiano algorithm in minimizing missing data 
(Keadle, Shiroma, Freedson & Lee, 2014).  
 While many studies have used 60 or 90 minutes to determine non-wear, in a fatigued or 
older population, allowing for longer periods of inactivity may be necessary to avoid eliminating 
data, which is actually sedentary time. Unnecessary elimination of data could lead to 
underestimation of sedentary time and overestimation of activity counts (Hutto et al., 2013).   
Hutto and colleagues pointed out that older, sedentary individuals can sit for quite some time and 
not register any accelerometer counts. Their study concluded that at least 120 minutes of 
consecutive zeroes should be used to determine non-wear in older adults. Subsequent studies 
allowed 150 minutes of zeroes before removing for non-wear (Hooker et al., 2016).  
 Initial data cleaning efforts in this study identified non-wear, using the Troiano and Choi 
algorithms but both resulted in frequent removal of data for non-wear, especially during the 
evening, a time when the participant was more likely sedentary rather than not wearing the 
device. Based on these preliminary findings and the rationale above noted by Hutto et al. (2013), 
a threshold of 120 minutes of continuous zeroes was used to define non-wear. Periods identified 
as non-wear were removed. 
 Given the possibility of increased fatigue and decreased physical activity in this 
population, allowing for even greater than 120 minutes may be appropriate to avoid removing 
what is actually sedentary activity rather than non-wear. Future studies may address this issue, as 
it may serve as a limitation of this study. 
Determining a Valid Day 
 In addition to determining non-wear, a valid day of accelerometer wear must also be 





wear (see Table 5). This method was adopted for this study, given how frequently this approach 
was used across numerous studies (Compernolle et al., 2017; Deere et al., 2016; Donaldson, 
Montoye, Tuttle & Kaminsky, 2016; Marmeleira, Laranjo, Marques & Pereira, 2014; Wolf-
Hughes, McClain, Dodd, Berrigan & Troiano, 2016). Initial scanning of data showed the clear 
majority fell into this category and would not result in undue removal of data. 
Actical accelerometer data used for this study was obtained from Microsoft Excel files, 
downloaded from the device at the time of use. These files were created by prior members of the 
research team, and in some cases, their data management decisions dictated the number of 
available valid days. Data from earlier participants were already truncated to a period of exactly 
72 hours, while data from more recent participants included data from the entire time the device 
was active, resulting in 3-5 days of valid data. In some cases, whole days of no data were 
present, and in other cases, there appeared to be activity, but based on the participant log, this 
movement actually represented transit of the device in the mail. Graphs and participants logs 
were used to determine start and end times. Since participants were instructed to wear the device 
at all times, even during sleep, each day of activity was required to have a corresponding night. 
Determining night time wear versus non-wear was difficult and may be a limitation to this study. 
Number of Valid Days Required for Analysis 
When creating a research protocol, investigators must decide the number of days to 
instruct participants to wear the device and how many days must be deemed valid to include their 
data. Many protocols require participants to wear the accelerometer for seven days with at least 
four of those days being valid (See table 5). To reduce participant burden, the existing protocol 
for this study required participants to wear the device for four days. Inclusion or exclusion of 





weekend day (Marmeleira, Laranjo, Marques & Pereira, 2014; Porcellis, Marques & Reichert, 
2018) or four weekdays and one weekend day (Westland et al., 2017). The existing protocol 
directed participants to wear the device for four days, including one weekend day. Given that 
four days of data were collected, it was not realistic to require four valid days, since many other 
studies requiring four valid days actually collected seven days of data. For this study, three valid 
days were required for inclusion. 
To help eliminate artifact and varying length of days from beginning and ending wear, 
Van der Berg and colleagues (2016) excluded the first and last days of data. In many cases, four 
days of data did not afford this luxury in this study; however, in many cases incomplete “days,” 
such as days with wear starting late in the day or ending early in the day could be removed, still 
preserving three valid days of measurement. 
Determining Accelerometer Wear Versus Non-Wear 
Determination of wear versus non-wear of the accelerometer is a key component of data 
management. Automated algorithms (Chu et al., 2018; Keadle, Shiroma, Freedson, & Lee, 
2014), specific software, (Cain & Geremia, 2012; Keadle, Shiroma, Freedson, & Lee, 2014) and 
manual methods are sometimes used. However, not all researchers have the resources or 
expertise to utilize software for automated identification of non-wear time. Rillamas-Sun and 
colleagues (2015) used graphs to identify a clear start of data, and visual inspection of data along 
with use of participant logs were used by several other research teams (Cain & Geremia, 2012; 
Joseph et al., 2018). Rillamas-Sun et al. (2015) found similar agreement between the use of logs, 
visual inspection, and algorithms.  
 Actical accelerometer data for this study was analyzed, using Microsoft Excel, visual 





and are useful for identifying time spent in sleep and non-wear time (Wolvers et al., 2018) as 
well as potentially useful in detecting outliers that should be eliminated from accelerometer data 
(Fuss et al., 2017). Creating a graph of all four days of data recorded at a specific time point 
allowed identification of clear start and end times of data in the majority of cases. Graphs also 
identified “gaps” in data, areas with no counts between areas of activity. These areas were then 
examined more closely to see if they met the 120-minute criteria for non-wear by manually 
checking all cells in that time period. Participant logs were reviewed for identified non-wear, 
such as showering or water sports. If a log noted “nap” or “sleep” during daytime hours, data 
during that time was not removed, even if it exceeded the 120-minute threshold. Participant logs 
were used to identify sleep and wake times. These times were correlated with graphed data for 
consistency. If sleep and wake times were not recorded, obvious sustained spikes in activity in 
the morning were interpreted as awakening and obvious cessation of sustained activity during 
night time hours was interpreted as sleep. The 120-minute non-wear algorithm was not applied 
during nighttime hours of sleep. 
Identifying Erroneous Values 
Handling values deemed to be erroneous is another task that must be undertaken when 
using accelerometry. Excessively high values recorded by accelerometers should be evaluated 
for accuracy and removed, if appropriate. Artifact frequently occurs with placement and removal 
of the device, so researchers may elect to remove the first and last one minute (Deere et al., 
2016) or five minutes (Chen & Bassett, 2005), immediately before placement and removal. 
Counts deemed excessive may be removed, such as >20,000 counts per minute (Loyen et al., 
2017; Vallance et al., 2014), using the Actigraph accelerometer, or for the Actical accelerometer 





(2016) discussed examining and removing excessive acceleration peaks without citing specific 
count per minute values. 
 In this study, graphs and individual cells were reviewed for excessive counts surrounding 
placement and removal of the device. Participants were instructed to wear the device at all times, 
including sleep, removing the device only for showering or other water activities. Participant 
logs indicated device placement and removal for these occasions. Data was scanned and 
compared with participant logs. Determination for removal of data was made by the researcher, 
based on the data pattern. Typically, activity counts higher than expected were seen for 
approximately one minute around the time of device placement. These elevations varied from 
very brief (one 15 second epoch) to longer periods (two minutes). The researcher felt that these 
peaks obviously represented device placement or removal artifact and decided to remove them 
rather than always removing data within a set time frame, such as one minute before or after 
device placement.  
 Aside from artifact from placement and removal of the device, obviously erroneous 
activity counts were very uncommon in this study. Activity logs were reviewed and compared 
with peak activity on graphs and when activity counts seemed above the level typical for a given 
participant. If an activity, such as exercise, running or other strenuous activity was recorded in 
the log, this was noted in the spreadsheet and the value left intact. On very rare occasions, a 
single value >10,000 cpm was identified and removed. These values were deleted with no 
imputation because they represented a very small percentage of the daily activity (1 minute or 







Imputation for Missing Data 
Various approaches for dealing with missing data exist. Catellier et al. (2005) developed 
a formula for imputation, based on mean physical activity level, BMI and other factors, while 
Cain and Geremia (2012) recommended using a mean activity score of valid days without 
imputation of missing data. Nastasi et al. (2018) discarded days with more than 5% missing data, 
imputing for missing values with the average over all days at the time point with missing data.  
 Days with multiple hours of missing data or non-wear may not meet the criteria for valid 
days as outlined above, and if so, were removed. The most common reason for missing data is 
removal of data due to non-wear, based on >120 minutes of consecutive zeroes or as noted in the 
participant log. Even with removal of non-wear time, the clear majority of data remains intact. 
For example, removal of two hours of non-wear is less than 3% of the total wear time of 72 
hours. The counts per minute variable is calculated by taking the total valid counts and dividing 
by the total minutes for the given measurement period. Thus, eliminating small amounts of data 
has less effect, since the minutes in the denominator decrease accordingly.  





Defining non-wear Troiano algorithm 
Non-wear = ≥ 60 consecutive 
minutes of zeroes 
Allowing for up to 2 minutes of 
counts < 100 
Baumann et al., 2018; 
Compernolle et al., 2017; 
Garcia-Hermoso et al., 2015; 
Troiano et al., 2008; Wolf-
Hughes, McClain, Dodd, 
Berrigan & Troiano, 2016 
  Choi algorithm 
Non-wear = 90 consecutive 
minutes of zeroes 
Allowing 2 minute5s of non-
zero if 30 minutes of zeroes 
above and below that value 
Choi, Liu, Matthews & 
Buchowski, 2011; Chu et al., 
2018; Keadle, Shiroma, 
Freedson, & Lee, 2014 
 
 Defining valid day ≥ 600 minutes of valid data (10 
hours) 
Compernolle et al., 2017; 
Deere et al., 2016; Donaldson, 
Montoye, Tuttle & Kaminsky, 
2016;  Marmeleira, Laranjo, 
Marques & Pereira, 2014; 
Wolf-Hughes, McClain, Dodd, 










Number of valid days 
required for analysis 
4 of 7 valid days Compernolle et al., 2017; Chu 
et al., 2018; Henson et al., 
2015; 
Keadle, Shiroma, Freedson, & 
Lee, 2014; Pozehl et al., 2018 
  3 of 7 including one weekend 
day 
Marmeleira, Laranjo, Marques 
& Pereira, 2014; Porcellis, 
Marques & Reichert, 2018 
Methods to 
determine non- 
wear and valid 
days 
 
Visual inspection Use of graphs to visualize clear 
start of data 
Rillamas-Sun, Buchner, Di, 
Evenson & LaCroix, 2015 
 
 
 Combined methods Non-wear determined with 
combination of Choi algorithm 
and logs 
Rillamas-Sun, Buchner, Di, 
Evenson & LaCroix, 2015 
Welch, Alexander, Swartz, 
Miller, Twardzik & Strath, 
2017 
  Visual inspection and logs Cain & Geremia, 2012; 
Joseph, Stromback, 




 Removal of first and last 5 
minutes of wear to avoid artifact 
Chen, Jerome, LaFerriere, 
Young & Vollmer, 2009 
  Removal of first and last 1 
minute after removing or 
replacing device 
Deere et al., 2016 
 
 








Duncan et al., 2018 
 
Hooker et al., 2016 
  Examination and removal of 
excessive acceleration peaks 




Accelerometer data were analyzed as total daily physical activity counts in one-minute 
epochs, as this yields counts per minute. Categorizing physical activity as sedentary, light, 
moderate, or vigorous is frequently used in physical activity research; however, previous work 
defining sedentary versus active groups in this population was not found in the literature. This 





hourly counts per minute (cpm), but due to lack of clear-cut points in the particular monitor used 
and in a fatigued group, this approach was not utilized. In this population, the small size of a 
non-sedentary group may prevent data analysis (M. El-Masri, personal communication, April 19, 
2018). Future work may focus on categorizing activity as sedentary, light, moderate, and 
vigorous. These categories with cut points based on cpm are commonly used (Duncan et al., 
2018). Frequently used cut points include those created by Colley and Tremblay (2011) and 
Freedson, Melanson and  Sirard, (1998).  
Statistical analysis was conducted using SPSS Version for Windows, Version 24. 
Pearson’s correlation was conducted with each variable (fatigue score, physical activity count, 
age, BMI, and hemoglobin level) at the three time points. The r statistic was calculated with 
degrees of freedom, based on number of participants in the sample and compared to a table for 
critical values of r using an α of .05 (Polit, 2010).  
FACT-F variables and accelerometer variables had a positive Shapiro-Wilk test (p < .05) 
so were considered not normally distributed. Other variables were examined for skewness and 
kurtosis, with values < 2, indicating a normal distribution. FACT-F scores were transformed as 
described in chapter 4.  
Accelerometer data were positively skewed, so data transformation was attempted. 
Square root transformation did not improve normality, but log transformation greatly improved 
skewness and kurtosis; therefore, the log-transformed variables were used for analysis. 
Linear regression analysis was used to investigate if there is a relationship between 
perceived fatigue scores and physical activity counts at the three study time points, while 
adjusting for baseline score (M. El-Masri, personal communication, October 16, 2017). Other 





are all continuous variables. Necessary assumptions include multivariate normality, the 
“assumption that each variable and all linear combinations of the variables are normally 
distributed” (Polit, 2010, p. 245), linearity, the assumption that “there is a straight line 
relationship between all pairs of variables” (p. 245) and homoscedasticity, “that the variability in 
scores for one variable is the same at all values of another variable” (p. 246).  
Limitations 
 
Patients undergoing treatment and enrolled in studies at NIH are a convenience sample 
and may not reflect the general population. They may have sought treatment at this location due 
to specialty referral, patient interest in being treated at a research institution, or other personal or 
geographic factors. These factors may affect their perception of and willingness to discuss their 
fatigue symptoms. Fatigue itself may limit energy and/or motivation to participate in completion 
of surveys and use of the accelerometer. Specific limitations of accelerometers, such as non-wear 
resulting in missing data, burden to participants, and utility in a fatigued population were 
discussed above.  Potential threats to validity include the potential motivation of physical activity 
measurement to increase physical activity above usual levels, and a highly motivated population 
of individuals who self-selected to participate in a research study at the NIH, which introduces 
the possibility of selection bias (Polit & Beck, 2012). Geographic differences may not be 
accounted for in this sample drawn mostly from the Washington, DC metropolitan area. Physical 
activity monitors present risk for error due to potential user and device factors. Participants may 
forget to wear the device, place it incorrectly, decide not to wear the device due to esthetic 
objections, or spend time in activities not compatible with accelerometer use, such as swimming. 





The approach used to determine accelerometer non-wear based on 120 minutes of activity 
counts may have led to unnecessary removal of data and may have increased average hourly 
activity counts slightly due to not recording sedentary activity. The Actical accelerometer is 
known to have difficulty measuring very low levels of activity (Duncan et al., 2018; Evenson et 
al., 2015). This may result in poor recording of movement during sleep, inability to detect wear 
during sleep from non-wear and could make differentiating daytime sedentary activity from light 
activity. 
Archived accelerometer data was used in this study. Accelerometer data was previously 
downloaded to Excel files and the raw data was not accessed by the researcher. Data was 
carefully examined for discrepancies as described in the data cleaning section, but some data 
files had been edited by previous researchers, limiting the amount of data for review. 
 This chapter has discussed the research design and strategy, methodology, criteria for 
inclusion and exclusion, protection of human subjects, and data collection procedures. Methods 
of measurement and instruments were detailed. Statistical methods for data analysis were 







Over the course of the NIH protocol (09-NR-0088), data was collected from 66 
participants at baseline (pre-EBRT), at midpoint, and at completion of EBRT. Five participants 
had missing or invalid physical activity count data at baseline and were excluded. Invalid 
physical activity count data is defined in this study as < 10 hours of valid data over < 3 
measurement days (See chapter 3 for details).  Four other participants withdrew before reaching 
completion of EBRT, bringing the total study sample to N = 57. Three participants had missing 
or invalid physical activity count data at midpoint and were excluded from analysis at that 
timepoint only. Pairwise deletion in SPSS was utilized to maintain sample size and remove 
participants from analysis only for missing variables. 
Demographic Characteristics of Sample 
The mean age of the sample was 65.51 years (SD ± 6.78; range = 53-84). Mean body 
mass index (BMI) was 29.88 mg/kg2 (SD ± 4.52; range = 21.60-43.90). The largest group of 
participants identified as Whites/Caucasian (n = 33; 57.9%), followed by African 
Americans/Blacks (n=18; 31.6%), three participants were Asians (5.9%), two were Hispanics 
(3.5%,) and one identified as “other” (1.8%). The majority of participants did not have a 
prostatectomy prior to RT (n=42, 73.7%) and had a Gleason score of 7 (n=27, 47.4%). See Table 





Table 6. Demographics 
  
Race Frequency Percent 
White 33 57.9 
African American/Black 18 31.6 
Asian 3 5.3 
Hispanic 2 3.5 
Other 1 1.8 
Total 57 100.0 
Ethnicity   
Hispanic or Latino 3 5.3 
Not Hispanic or Latino 52 91.2 
Unknown 2 3.5 
Total 57 100.0 
Prostatectomy   
No 42 73.7 
Yes 15 26.3 
Total 57 100.0 
Gleason Score   
6 4 7.0 
7 27 47.4 
8 17 29.8 
9 9 15.8 
Total 57 100.0 
 
Continuous Variables 
Table 7 lists values for the continuous variables at the three study time points. Physical 
activity counts measured by the Actical accelerometer, expressed as counts per minute (cpm), 
varied greatly between participants. At baseline the mean was 78.51 cpm (SD ± 49.59; range = 
9.97-254.21), the mean at midpoint of EBRT was 75.36 cpm (SD ± 43.53; range = 13.95-
259.52), and at completion of therapy was 69.97 cpm (SD ± 53.72, range = 8.92-275.51). 
Standard deviations for all evening physical activity counts, collected from 1400-1800 were 
quite large, at baseline (M= 127.4, SD=123.6), midpoint (M = 117.3, SD=89.99) and completion 
(M = 113.3, SD =102.00), likely due to the variation in physical activity and shorter period of 











Deviation Min Max 
BMI 29.88 4.52 21.60 43.90 
Hgb (baseline) 13.98 .920 12.00 16.60 
Hgb (midpoint) 12.96 1.094 10.30 15.40 
Hgb (completion) 12.77 1.068 10.80 15.80 
FACT-F (baseline) 43.09 9.255 6 52 
FACT-F (midpoint) 40.14 10.081 16 52 
FACT-F (completion) 39.64 9.734 13 52 
PROMIS-SD (baseline) 47.67 9.518 28.90 66.10 
PROMIS SD (midpoint) 48.82 9.591 28.90 67.50 
PROMIS SD- (completion) 48.88 10.347 28.90 64.90 
Total activity cts. (baseline) 78.51 49.593 9.96 254.21 
Evening activity cts. (baseline) 127.40 123.658 12.77 750.61 
Total activity cts (midpoint) 75.36 43.531 13.95 259.53 
Evening activity cts (midpoint) 117.32 89.986 5.44 459.75 
Total activity cts (completion) 69.97 53.722 8.92 275.51 
Evening activity cts (completion) 113.29 102.00 11.97 458.70 
 
BMI= Body Mass Index; FACT-F= Functional Assessment Cancer Treatment-Fatigue, Hgb= 
Hemoglobin, PROMIS-SD= Patient Reported Outcomes Measurement Information System-
Sleep Disturbance; Total activity counts= Actical accelerometer daily counts per minute; 
Evening activity counts = 1400-1800 Actical accelerometer counts per minute 
 
Addressing Normality of Data 
 All variables were examined for normality. In all time points, PROMIS-SD, BMI, age, 
and Hgb had skewness and kurtosis < 1.96. These values meet the requirement for normality 
(Ghasemi & Zahediasl, 2012; Laerd Statistics, 2015). All FACT-F and physical activity variables 
had positive Shapiro-Wilk tests (p <.05), which indicates lack of normality.  Fatigue scores 
(FACT-F) were not normally distributed at baseline or completion of therapy (See Table 8). 
Skewness/standard error at baseline = -5.15, kurtosis/standard error = 5.81. At completion of 





midpoint, skewness and kurtosis/standard error were both < 2 (-1.97, -1.04, respectively). Based 
on these values not being normally distributed at two study time points, variable transformation 
was carried out. FACT-F scores were moderately negatively skewed so were transformed, using 
the reflect and square root method (Laerd Statistics, 2015). In this method, one is added to the 
highest recorded value in the data set, which is 52 for FACT-F.  The FACT-F score was 
subtracted from 53, and the square root was taken of that value. This transformation resulted in 
skewness and kurtosis/ standard error of < 1.96 for all transformed variables (See Table 8).  
Of note, the reflect and square root method changed the direction of the fatigue scale, 
where for the original FACT-F scale, a higher number indicates less fatigue. Once FACT-F 
scores were transformed, using this method, a lower number means less fatigue. The 
transformation of FACT-F scores, using the reflect and square root method, allowed these 
fatigue scores to be interpreted the same way as the PROMIS scores, where a higher number 
means higher fatigue. In this case, correlations that are actually positive before transformation 
appear to be negative. This change is important to note in interpreting the findings of this study.  
Physical activity count variables in all time points had skewness and kurtosis/standard 
error well over the acceptable range (See Table 8) of 1.96 (Ghasemi & Zahediasl, 2012) or 2.58 
(Laerd Statistics, 2015). Data was positively skewed, so square root transformation was 
attempted but did not bring skewness and kurtosis values within acceptable levels. Log 10 
transformation was carried out, yielding skewness and kurtosis values <2 for all but one value 








Table 8. Original and Transformed Variables 
 
Variable Skewness Std error Skewness/ 
Std error 
Kurtosis Std error Kurtosis/ 
Std error 
FACT-F (baseline) -1.628 .316 -5.15 3.620 .623 5.80 
FACT-F (midpoint) -.624 .316 -1.97 -.647 .623 -1.04 
FACT-F (completion) -.670 .319 -2.10 .167 .628 0.27 
Total activity counts 
(baseline) 
1.265 .316 4.00 1.878 .623 3.01 
Evening activity counts 
(baseline) 
2.868 .319 8.99 11.171 .628 17.79 
Total activity counts 
(midpoint) 
1.806 .325 5.56 5.370 .639 8.40 
Evening activity counts 
(midpoint) 
1.622 .325 4.99 3.240 .639 5.07 
Total activity counts 
(completion) 
2.044 .316 6.47 4.593 .623 7.37 
Evening activity counts 
(completion) 
1.777 .316 5.62 2.979 .623 4.78 
Transformed Variables 
FACT- reflect and 
square root 
       
FACT-F (baseline) .533 .316 1.687 -.190 .623 -0.305 
FACT-F (midpoint) .045 .316 0.142 -1.150 .623 -1.846 
FACT (completion) -.111 .319 -0.348 -.862 .628 -1.373 
Activity counts- Log 
transformed 
      
Total activity counts 
(baseline) 
-.285 .316 -0.902 .010 .623 .016 
Evening activity counts 
(baseline) 
.057 .319 0.179 .251 .628 0.340 
Total activity counts 
(midpoint) 
-.395 .325 -1.22 .580 .639 0.908 
Evening activity counts 
(midpoint) 
-.692 .325 2.129 1.282 .639 2.006 
Total activity counts 
(completion) 
.022 .316 0.070 .424 .623 0.681 
Evening activity counts 
(completion) 
-.107 .316 -0.339 -.429 .623 -0.689 
 
BMI= Body Mass Index; FACT-F= Functional Assessment Cancer Treatment-Fatigue, Hgb= 
Hemoglobin, PROMIS-SD= Patient Reported Outcomes Measurement Information System-
Sleep Disturbance; Total activity counts= Actical accelerometer daily counts per minute; 









 Fatigue increased at midpoint of therapy and persisted at completion. FACT-F means at 
baseline (M= 43.09, SD= 9.26), midpoint of therapy (M= 40.14, SD= 10.08), and completion 
(M= 39.64, SD= 9.73) showed a clinically significant difference in mean fatigue scores, as 
measured by a decrease in FACT-F >3. This approach of determining clinical significance of 
fatigue based on a change in FACT-F > 3 is based on a previous report (Feng et al., 2016).  
Relationships between fatigue and study variables other than physical activity are 
illustrated in Table 9. At baseline, prior to EBRT, age had a negative correlation with FACT-F 
scores (r= -.29, p=.03), indicating that older participants reported less fatigue than younger 
participants. No relationship was found between age and fatigue at subsequent time points. BMI 
was not significant at baseline but was positively correlated with fatigue scores at midpoint 
(r=.32, p=.01) and completion of therapy (r=.30, p=.03). This correlation indicates higher fatigue 
in participants with higher BMI. Hemoglobin at midpoint was negatively correlated with fatigue 
at midpoint (r=-.48, p=<.005) and completion of therapy (r=-.40, p=.002), indicating worsening 
fatigue with lower hemoglobin levels. Hemoglobin at completion was also negatively associated 
with fatigue at midpoint (r= -.53, p<.005) and completion of therapy (r=-.41, p=.001). PROMIS-
SD was correlated with fatigue at all time points, indicating worsening fatigue occurring with 












Age BMI Hgb  
(baseline) 














-.29* 0.23 0.11 -0.12 -0.18 .49** .38** .48** 
 





-0.12 .32* -.30* -.48** -.53** .34* .33* .47** 
 





-0.11 .30* -0.21 -.40** -.41** .31* .34* .47** 
 
Sig. (2-tailed) 0.43 0.03 0.12 0.002 0.001 0.02 0.01 <.005  
N 56 56 56 54 56 56 56 56 
** Significance= p <.05 based on a 2-tailed alpha of 0.05 
BMI= Body Mass Index; FACT-F= Functional Assessment Cancer Treatment-Fatigue, Hgb= Hemoglobin, PROMIS-SD= Patient 
Reported Outcomes Measurement Information System-Sleep Disturbance; Total activity counts= Actical accelerometer daily 
counts per minute; Evening activity counts = 1400-1800 Actical accelerometer counts per minute 









Table 10: Pearson Correlations Between Activity and Non-Fatigue Study Variables 
 















-0.26 -0.14 0.05 0.25 0.12 -0.01 0.15 0.06 
 





-0.22 -0.21 0.00 0.12 -0.05 0.05 0.10 0.10 
 




-0.22 -0.10 -0.03 0.09 -0.04 -0.15 0.00 -0.04 
 





-0.15 -0.07 -0.04 0.17 -0.03 -0.07 -0.09 0.01 
 




-0.26 -0.22 0.14 0.18 0.10 0.05 0.11 0.05 
 





-0.19 -0.18 0.07 0.17 0.08 0.09 0.05 0.11 
 
0.17 0.18 0.62 0.23 0.57 0.51 0.69 0.44 
** Significance= p <.05 based on a 2-tailed alpha of 0.05 
BMI= Body Mass Index; FACT-F= Functional Assessment Cancer Treatment-Fatigue, Hgb= Hemoglobin, PROMIS-SD= Patient 
Reported Outcomes Measurement Information System-Sleep Disturbance; Total activity counts= Actical accelerometer daily 
counts per minute; Evening activity counts = 1400-1800 Actical accelerometer counts per minute 




































-0.04 -0.02 -0.04 -0.06 -0.02 -0.11 
 
  0.78   0.86   0.79   0.65   0.87   0.40 
FACT-F 
(midpoint) 
-0.14 -0.10 -0.10 -0.07 -0.18 -0.12 
 
  0.29   0.46   0.49   0.62   0.17   0.39 
FACT-F 
(completion) 
-0.15 -0.17 -0.17 -0.18 -0.25 -0.17 
 
  0.26   0.21   0.23   0.21   0.07   0.21 
** Significance= p <.05 based on a 2-tailed alpha of 0.05 
BMI= Body Mass Index; FACT-F= Functional Assessment Cancer Treatment-Fatigue, Hgb= Hemoglobin, PROMIS-SD= 
Patient Reported Outcomes Measurement Information System-Sleep Disturbance; Total activity counts= Actical accelerometer 
daily counts per minute; Evening activity counts = 1400-1800 Actical accelerometer counts per minute 







Physical Activity  
 Total activity counts and evening activity counts did not correlate with any of the study 
variables (See Table 5). The relationship between age and physical activity approached 
significance (p=0.05) at baseline (r=-.26) and completion (r=-.26) indicating lower activity 
levels in older participants. (See Table 10). 
Relationship of Fatigue and Physical Activity 
  
 Physical activity, both total and evening, did not show correlation with fatigue scores at 
baseline, midpoint or completion of therapy. (See Table 11). 
Regression Analysis 
Multiple linear regression analysis was carried out to identify the independent predictors 
of fatigue (e.g., BMI, hemoglobin, PROMIS-SD and physical activity counts) at midpoint of 
therapy and at conclusion of therapy while adjusting for baseline fatigue score. Age was not 
correlated with fatigue at midpoint or conclusion of therapy, thus was not included in the model. 
Four separate models were carried out. All models used BMI, hemoglobin and PROMIS-SD at 
their respective time points, as well as baseline FACT-F scores. Transformed variables were 
used for FACT-F and physical activity counts, as previously described. Regression models were 
created as below: 
1. Midpoint of therapy: total physical activity counts 
2. Midpoint of therapy: 1400-1800 physical activity counts 
3.  Conclusion of therapy: total physical activity counts 
4. Conclusion of therapy: 1400-1800 physical activity counts 
 Assumptions for all models were assessed as follows. Multicollinearity was not present, 




to 2.0 indicating independence of errors. Linearity and homoscedasticity were assessed using 
visual inspection of scatterplots for each variable and were not found to be problematic.  All 
tolerance values were greater than 0.1, indicating that collinearity was not present.  Outliers were 
assessed, and no standardized residuals were greater than ± 3. Three leverage values were greater 
than 0.2; however, no Cook’s distance values were greater than 1.  No outliers were removed 
from analysis. Normality was assessed by visual inspection of a histogram and P-P plot of 
regression standardized residual. 
 The regression models were predictive of fatigue score at both midpoint and completion 
of therapy, using separate models for total physical activity count and evening physical activity 
count.  
Midpoint of therapy: Model 1: p<.005, adj. R2= .627. Model 2: p<.005, adj. R
2
= .628 
Completion of therapy: Model 3: p<.005, adj. R2 = .513. Model 4: p<.005, adj. R2= .481. 
Table 12. Summary of Multiple Regression Analysis-Midpoint, Total Physical Activity Counts 
 
  Variable B SEB Β P 
(Constant) 6.468 2.033  .002 
FACT-F (baseline) .662 .097 .622 <.005 
BMI .049 .028 .149 .083 
Hgb (midpoint) -.503 .113 -.371 <.005 
PROMIS-SD (midpoint) .006 .014 .036 .688 
Total activity counts 
(midpoint) 
-.156 .503 -.026 .758 
Note. Dependent Variable: FACT-F (midpoint) 
B= unstandardized regression coefficient; SEB = Standard error; β = standardized coefficient 
BMI= Body Mass Index; Hgb= Hemoglobin, PROMIS-SD= Patient Reported Outcomes 
Measurement Information System-Sleep Disturbance; Total activity counts= Actical 
accelerometer daily counts per minute 
 
For all four models, hemoglobin and baseline fatigue were significant predictors of 
fatigue at midpoint and completion of therapy. BMI, PROMIS-SD and evening physical activity 




significant predictor of fatigue at completion of therapy only. See Tables 1-4 for regression 
coefficients and standard errors. 
Table 13. Summary of Multiple Regression Analysis – Midpoint, 1400-1800 Physical Activity 
Counts 
 
Variable B SEB Β P 
(Constant) 5.993 1.972  .004 
FACT-F (baseline) .664 .096 .623 <.005 
BMI .051 .028 .154 .074 
Hgb (midpoint) -.518 .114 -.382 <.005 
PROMIS SD (midpoint) .005 .014 .035 .697 
Evening activity counts 
(midpoint) 
.177 .353 .042 .618 
Note. Dependent Variable: FACT-F (midpoint) 
B= unstandardized regression coefficient; SEB = Standard error; β = standardized coefficient 
BMI= Body Mass Index; Hgb= Hemoglobin, PROMIS-SD= Patient Reported Outcomes Measurement 
Information System-Sleep Disturbance; Evening activity counts= Actical accelerometer 1400-1800 
counts per minute 
 
Table 14. Summary of Multiple Regression Analysis-Completion, total Physical Activity Counts 
Variable B SEB Β P 
(Constant) 5.547 2.501  .031 
FACT-F (baseline) .521 .113 .503 <.005 
BMI .027 .032 .085 .397 
Hgb (completion) -.298 .139 -.217 .038 
PROMIS SD 
(completion) 
.020 .016 .146 .202 
Total activity counts  
(completion) 
-.949 .470 -.196 .049 
Note. Dependent Variable: FACT-F (completion) 
B= unstandardized regression coefficient; SEB = Standard error; β = standardized coefficient 
BMI= Body Mass Index; Hgb= Hemoglobin, PROMIS-SD= Patient Reported Outcomes Measurement 






Table 15. Summary of Multiple Regression Analysis – Completion, 1400-1800 Physical Activity 
Counts 
 
Variable B SEB Β P 
(Constant) 4.458 2.519  .083 
FACT-F (baseline) .508 .118 .491 <.005 
BMI .036 .032 .113 .273 
Hgb (completion) -.310 .144 -.227 .036 
PROMIS SD 
(completion) 
.020 .017 .145 .227 
Total activity counts  
 
-.332 .381 -.089 .387 
Note. Dependent Variable: FACT-F (completion) 
B= unstandardized regression coefficient; SEB = Standard error; β = standardized coefficient 
BMI= Body Mass Index; Hgb= Hemoglobin, PROMIS-SD= Patient Reported Outcomes 
Measurement Information System-Sleep Disturbance; Evening activity counts= Actical 
accelerometer 1400-1800 counts per minute 
 
Summary of Findings 
Fatigue scores had significant Pearson’s correlations with BMI and hemoglobin at 
midpoint and completion of therapy. Higher BMI and lower hemoglobin were associated with 
higher fatigue scores. PROMIS-SD scores correlated with fatigue scores in all time points, 
indicating that worsening fatigue and sleep disturbance may co-occur.  Total physical activity 
and evening physical activity were not correlated with any of the study variables. 
Regression models were predictive of fatigue at midpoint and completion of therapy, with 
baseline fatigue and hemoglobin showing significance in all models. Total physical activity 






 This chapter presents a summary of the study, conclusions drawn from the study, 
implications and recommendations for future research. 
Summary 
Fatigue is reported to be the most distressing side effect of radiation therapy (RT), 
negatively effecting physical function and quality of life (Minton et al., 2013). This study 
explores the relationship of fatigue with free-living activity measured through accelerometry, 
which has been largely unexplored in men receiving RT (EBRT) for prostate cancer. Finding 
measures to predict, treat, and help prevent fatigue can improve long-term outcomes in cancer 
treatment. 
The purpose of this study was to explore the adjusted relationship between physical 
activity count and perceived fatigue scores in men with non-metastatic prostate cancer, receiving 
external beam RT at beginning, midpoint, and end of therapy. 
Research Questions: 
1. Is there a relationship between physical activity and fatigue at baseline, 
midpoint of therapy, and conclusion of therapy? 
2. Does physical activity predict fatigue at midpoint, and completion of 
EBRT? 
The National Institutes of Health Symptom Science Model (NIH-SSM) was the 
theoretical framework guiding this study. The basic premise of the NIH-SSM is that complex 




which can lead to clinical applications. This study will contribute to the connection 
between symptoms and phenotype of cancer-related fatigue. 
An observational, correlational study was utilized to examine the relationship between 
physical activity level (activity counts) and perceived fatigue at three time points, baseline (prior 
to EBRT), midpoint (Day 19-21), and post-therapy (Day 38-42). This study assessed free-living 
physical activity, measured with an accelerometer and through daily logs and perceived fatigue, 
measured with the Functional Assessment of Cancer Therapy-Fatigue FACT-F at the beginning, 
midpoint, and conclusion of EBRT in men with prostate cancer. 
The study was conducted at the National Institute for Nursing Research (NINR). Data 
was collected by the NINR team at the Hatfield Clinical Research Center of the National 
Institutes of Health (NIH). Data was gathered from study databases, participant records, and the 
NIH Clinical Center medical record. Accelerometry data was retrieved from the secure NINR 
server. Accelerometry data was inspected and cleaned by the investigator. This process includes 
determining amount of time the device was worn, locating and removing periods of non-wear, 
assessing for erroneous values, and determining physical activity counts (Deere et al., 2016). 
Physical activity counts were calculated for the entire wear period and for the hours of 2:00pm-
6:00pm, a time period shown to have significant radiation-induced fatigue in an animal model 
(Renner et al., 2016). 
Statistical analysis was conducted to determine correlations between physical activity 
count and fatigue scores. Pearson’s correlation was conducted with each variable (fatigue score, 
physical activity count, age, BMI, hemoglobin level, sleep disturbance score, and age) at the 
three study time points. Linear regression analysis investigated if there was a relationship 




while adjusting for baseline fatigue score. Other variables used in regression analysis include 
age, BMI, hemoglobin, and sleep score, all continuous variables. Linear regression analysis was 
utilized with fatigue and physical activity count as the dependent and independent variables, 
respectively, controlling for baseline fatigue and physical activity, age, BMI, hemoglobin, and 
sleep as potential confounding variables. 
Major Findings 
Few studies have examined objectively measured physical activity, using an 
accelerometer along with fatigue measured with the FACT-F in men receiving EBRT for 
prostate cancer. Fatigue was correlated with sleep disturbance in all study time points and with 
hemoglobin at midpoint and completion of therapy. Physical activity reached a p=.05 when 
correlated with age at baseline and completion of therapy but was not correlated with other study 
variables. Pearson’s correlation showed no relationship between physical activity and fatigue. 
Hemoglobin and baseline fatigue were predictive of fatigue in all time points, using regression 
analysis. Total physical activity counts were predictive of fatigue at completion of therapy. This 
study reinforces the relationship of fatigue with hemoglobin and sleep disturbance as well as 
sleep disturbance and baseline fatigue as predictors of fatigue during treatment and at completion 
of EBRT. Total physical activity had not been identified as a predictor of fatigue at completion 









Table 16. Summary of findings by time point 
 
 Baseline Midpoint Completion 
Correlations with 
increased Fatigue 
Sleep disturbance Sleep disturbance Sleep disturbance 
 Younger age Lower hemoglobin Lower hemoglobin 




Older age (p=.05)  Older age (p=.05) 







Findings Related to the Literature 
Trajectory of Fatigue 
 The trajectory of fatigue in this study followed the general trend of fatigue symptoms 
during EBRT, as previously published, which is worsening at midpoint (Feng et al., 2017; Feng, 
Wolff et al., 2016; Filler et al., 2016; Hsiao, Reddy, Chen & Saligan, 2015). However, this study 
did not find any improvement in fatigue symptoms at completion of EBRT. While means at 
baseline (M= 43.09, SD= 9.26), midpoint of therapy (M= 40.14, SD= 10.08, and completion 
(M= 39.64, SD= 9.73) did not differ greatly, a clinically significant difference in mean fatigue 
scores, as measured by a decrease in FACT-F >3, was found between baseline and completion of 
therapy. This approach of determining clinical significance of fatigue is based on a previous 
report (Feng et al., 2016).  
The trajectory of fatigue observed in this study is consistent with other cancer 
populations receiving RT, or even those receiving chemotherapy or a combination of chemo and 
radiation therapies. Fatigue, worsening during therapy and continuing to completion, has been 




(Hacker, Kim, Park & Peters, 2017).  These findings confirm the behavioral consequences of 
cancer therapies, which may be explained by several physiological processes. 
Correlates of Fatigue 
Fatigue was correlated with several factors in this study. At baseline, fatigue was 
negatively correlated with age, indicating that younger participants reported greater fatigue. This 
finding is congruent with findings in patients undergoing RT (Poirier, 2006) and specifically 
patients receiving EBRT for prostate cancer (Chao, Doucett, Raizen, & Vapiwala, 2018; 
Miaskowski et al., 2008). Since the mean age of participants is around retirement age, it is 
possible that younger participants were still in the workforce and faced with daily activities and 
stressors that may be fatiguing, with less time for rest or other self-care activities than their older, 
retired counterparts. In individuals with breast cancer, having children at home, being employed 
and younger age were all correlated with worse fatigue (Dhruva et al., 2013).  In our study the 
correlation did not persist during or after therapy; however, and may indicate greater importance 
of other factors, such as BMI and hemoglobin which were correlated with fatigue at midpoint 
and completion of therapy, despite no relationship being evident at baseline. 
 BMI was correlated with fatigue at midpoint and completion of therapy. This correlation 
was found in colorectal cancer survivors (Vissers et al., 2017) and breast cancer (Gerber et al., 
2011), but was not found in another breast cancer study (Kenzik et al., 2018).  BMI did not differ 
between fatigued and non-fatigued groups in men receiving EBRT for prostate cancer (Feng, 
Espina & Saligan, 2018). Given the wide-ranging effects of elevated BMI, including increased 
risk for hypertension, diabetes mellitus, coronary heart disease and stroke, among others, 
(NHLBI, 2013), it is not surprising that men with a higher BMI may be less prepared 




known to increase inflammation and insulin resistance and lead to dyslipidemia which can 
contribute to chronic disease (Gerber et al., 2011; Guttieriz, Puglisi & Hasty, 2009; Vissers et al., 
2017). Inflammation is a proposed mechanism of fatigue (Saligan et al., 2015) and reduction in 
inflammatory markers associated with exercise have been correlated with decreased fatigue 
(Hojan et al., 2017). 
 Anemia is a well-documented factor in radiation-induced fatigue (Cella et al., 2002; Feng 
et al., 2015; Hsiao, Daly & Saligan, 2016), and a decrease in hemoglobin was significantly 
associated with fatigue in this study. Similar to BMI, baseline hemoglobin level was not 
correlated with fatigue, but was significantly associated with fatigue at both midpoint and 
completion of therapy. Destruction of blood cells during radiation eventually results in less 
oxygen delivery to tissues resulting in fatigue (Feng et al., 2015; Khoshbin et al., 2014; Pinkawa 
et al., 2014). 
 Sleep disturbance was associated with fatigue in all time points of this study. Cancer 
related fatigue and sleep disturbance often occur as part of a symptom cluster and are thought to 
have similar etiologies stemming from inflammation, eventually leading to skeletal muscle 
dysfunction, manifesting as fatigue and sleep problems, among others (Charalambous et al., 
2019; Saligan et al., 2015).  This has been observed in breast cancer (Berger, Kupzyk, Djalilova 
& Cowan, 2019; Overcash, Tan, Patel & Noonan, 2018), and sleep disturbance has been shown 
to co-occur in men receiving EBRT for prostate cancer, which may be worsened by urinary 
symptoms, specific to this population (Feng, Fuss, Dickinson, Ross & Saligan, 2019).  
Physical Activity 
Physical activity did not vary greatly between time points but did show a downward trend 




midpoint and reduced further at completion of therapy, despite remaining well within the 
standard deviation. 
Total physical activity was not significantly correlated with any of the study variables, 
although a p= .05 was found between total physical activity and age at baseline and completion 
of therapy. Older participants tended to be less active than younger participants, in this study. 
These mixed results are not surprising, given the mixed effects of age on physical activity in the 
literature. Older men with prostate cancer were less likely to exercise (Bohn, Fossa, Wisloff & 
Thorsen, 2019), and older patients with cancer related fatigue were more likely to be sedentary 
(Wolvers et al., 2017). However, age was also reported to not be associated with physical 
activity level in cancer survivors (Dennett, Peiris, Shields & Prendergast, 2018). It is possible 
that physical activity levels are dictated more by social roles, where younger participants who are 
in the workforce or involved in more social activities simply need to be more active. Not 
working or being retired was associated with a decrease in physical activity, with physical 
activity levels peaking at age 60 and decreasing with age (van Adrichem et al., 2018).  This 
rationale may explain the association of age and fatigue observed at baseline, in this study. 
Younger participants may not be more physically active by choice but because they feel the need 
to meet their daily obligations, possibly even despite worsening fatigue. 
 Fatigue has been shown to increase in the afternoon and evening in patients treated with 
RT for non-metastatic cancer (Dhruva et al., 2013; Miaskowski & Aouizerat, 2012) and was 
observed in an animal model as well (Renner et al., 2016). Evening physical activity was not 
associated with other variables in this study. These values had very large standard deviations due 
to the shorter period of time observed. While data was not classified into physical activity 




in some participants. Sedentary behavior during evening hours, in this population, warrants 
further investigation. 
 Physical activity was not correlated with BMI, in any study time points. BMI was related 
to physical activity in breast cancer patients in a structured exercise program (Kenzik et al., 
2018) and in colon cancer but has not been significant in the prostate cancer population (Feng et 
al., 2018; Feng, Espina & Saligan, 2018).  
Physical Activity and Fatigue 
 A major goal of this study was to investigate the relationship of physical activity and 
fatigue in men receiving EBRT for prostate cancer.  A mechanism proposed in a breast cancer 
study states individuals who exercise regularly get the benefit of decreased serum pro-
inflammatory cytokines, increased insulin sensitivity and improved glucose uptake seen with 
exercise and failure to mitigate these factors may lead to fatigue (Gerber et al., 2011).  
This study investigated overall daily physical activity related to fatigue. Previously, a 
relationship was observed by Minton and Stone (2012) and Jim et al. (2011) using this 
methodology. In this study no correlations were found with fatigue and total or evening physical 
activity counts, however physical activity was predictive of fatigue at completion. The literature 
in this area is mixed. Fatigue was correlated with physical activity in patients with lymphoma 
(Vermeate, Wolter, Verhoef & Gosselink, 2014), but not in advanced cancer (Yennurajalingam 
et al., 2016). In prostate cancer, while deemed clinically significant by the authors, increasing 
physical activity was not found to be statistically significant in relation to fatigue as measured as 
a subscale of quality of life (Gaskin et al., 2016). A strong inverse relationship was found 
between physical activity and fatigue, with fatigue being a limiting factor in activity for cancer 




an accelerometer capable of recording fatigue in real time, rather than questionnaires that require 
recall. This may be a useful method to consider in future research. 
 This study examined physical activity counts as a continuous variable and did not 
categorize physical activity as sedentary, light or moderate. In the literature, fatigue was 
associated with increased sedentary time (Phillips et al., 2016), and the amount of decline in 
physical activity seen as the day progresses (Timmerman et al., 2015). The method used in this 
study is unable to detect an increase in sedentary time for a particular participant or track it over 
time.  
Predictive Model 
 It may be possible to predict fatigue based on other known factors. Identifying 
individuals at risk for fatigue may allow for timely education and interventions. Hemoglobin and 
baseline fatigue were significant predictors of fatigue at midpoint and completion of therapy. 
This confirms previous work in patients with prostate cancer undergoing EBRT where 
hemoglobin was predictive of fatigue (Feng et al., 2015), also demonstrating baseline fatigue as 
predictive of fatigue during treatment. Baseline fatigue has been shown to predict fatigue during 
therapy in mixed cancers (Susanne et al., 2015) and in breast cancer (Schmidt et al., 2015).  
 Total physical activity was predictive of fatigue at completion of therapy, in this study. 
The negative correlation observed indicates an inverse relationship between physical activity and 
fatigue; meaning, more active individuals are likely to be less fatigued, or less fatigued 
individuals are more active. This finding has been noted in breast cancer (Berger et al., 2019; 
Gerber et al., 2011) but to our knowledge, this predictive relationship has not been noted in men 






 This study has further demonstrated the correlation of hemoglobin and sleep disturbance 
with fatigue in men with prostate cancer, as found in previous studies. It has solidified the 
concept that hemoglobin at baseline is a valid predictor of fatigue and demonstrated that 
decreased physical activity is predictive of fatigue at completion of therapy. 
 Physical activity showed no correlation with study variables at baseline or midpoint but 
was predictive of fatigue at completion of therapy. Age and physical activity approached 
significance at p=.05 both at baseline and completion of therapy. Possibly, a larger sample size 
would have yielded significant results, indicating lower levels of physical activity with 
increasing age. At baseline, younger participants manifested greater fatigue. This suggests that 
physical activity and fatigue are largely separate constructs in this population. 
 Physical activity was predictive of fatigue at completion of therapy. Perhaps by this 
point, the mental and physical toll taken by a busy schedule of daily radiation and the ensuing 
fatigue manifests as a decrease in physical activity, but this is not evident prior to that time. A 
noticeable decrease in physical activity should warrant assessment for fatigue.  
Most physical activity research is not limited only to men; therefore, factors unique to 
them may be overlooked. There may be a sense of pressure to work for financial reasons or to 
provide for the needs of family members. Men may feel that showing signs of fatigue by slowing 
down physical activity may be seen as a sign of weakness.  
 The mean age of this study is approximately 65 years and individuals in this age range 
can have responsibilities that must be attended to, regardless of fatigue. They may still be in the 
workforce, unable to alter their daily routine significantly. They may have dependent spouses, 




need for travel to and from appointments may increase their physical activity level and mask any 
effect fatigue has on their mean daily physical activity. No longer having the need for daily 
appointments could lead to a decrease in physical activity or allow activity to be more in line 
with what feels appropriate to the individual. The effect of radiation is cumulative and, in many 
cases, persists beyond treatment. As time goes on, the men’s ability to cope with fatigue may 
decrease and physical activity may subsequently decrease as well. 
 This study did not quantify time spent in sedentary activity; however, based on 
observation of raw physical activity data, many participants had sedentary lifestyles, even at 
baseline. With less total physical activity to begin with, the effect of fatigue on decreasing 
physical activity may not be noticeable.  
Nursing Implications 
This study reinforces that hemoglobin, sleep disturbance and baseline fatigue are strong 
predictors of fatigue in men receiving EBRT for prostate cancer. Mean hemoglobin levels 
decreased by > 1 mg/dl from baseline to completion, decreasing from 13.98 mg/dl to 12.77 
mg/dl. This decrease crosses the threshold of anemia, 13.2 mg/dl for white men over 60 (Beutler 
& Waalen (2006) and can be considered clinically significant. Healthcare professionals should 
monitor for these factors and provide appropriate patient teaching regarding the likelihood of 
fatigue. A decrease in physical activity is predictive of fatigue at completion of therapy. Patients, 
families and health care professionals should monitor for changes in physical activity and be 
alert for subsequent fatigue. Knowing when to expect symptoms may reduce distress felt by the 
patient and family and allow daily activities to be planned accordingly. 
 Except for at completion of therapy, there was no relationship between physical activity 




experiencing fatigue, but it may not be readily apparent since physical activity level is not 
affected. Factors such as employment, home obligations and attitudes about fatigue should be 
explored. If physical activity is noted to decrease, this may represent an increase in fatigue or 
decreased ability to deal with its effects.  
 In this study, fatigue was worse in younger individuals at baseline and was not related to 
physical activity until completion of therapy. This indicates that external factors such as work, 
family or other commitments may play a role. Younger patients should be assessed for fatigue so 
that education and possible interventions can be provided.   
Structured exercise consisting of both endurance activities such as walking and resistance 
exercise such as the use of light weights is recommended both during and following cancer 
treatment to help reduce fatigue (NCCN, 2017). In younger, more active patients, individualized 
timing of activities may be important to allow for rest periods, understanding that the need for 
home and work activities may be greater and may be perceived as more fatiguing. A possible 
nursing care plan may include planning ADLs and IADLs to allow for periods of rest while 
incorporating endurance and resistance exercise to potentially help mitigate fatigue. This may 
lead to an overall increase in physical activity but may be more congruent with the patient’s 
energy level. 
Future Research 
 Physical activity data should be incorporated with fatigue scales and other measures to 
further refine the phenotype of cancer related fatigue. Similar to phenotype development using 
fatigue scales (Feng et al., 2016), categories based on physical activity level could be used to 
explore biomarkers for individuals likely to experience a decrease in physical activity. This will 




Future research in this area should examine changes in physical activity from morning to 
evening, since fatigue is thought to worsen as the day goes on (Dhruva et al., 2013; Miaskowski 
& Aouizerat, 2012). Patterns of fatigue could be identified, and daily activities can be planned 
accordingly. 
Physical activity should be categorized to determine sedentary time to compare sedentary 
and more active individuals in relation to fatigue. Currently available devices are more sensitive 
to sedentary activity than those used in this study and may offer the possibility of real-time 
fatigue monitoring. Newer devices also have a greater ability to monitor movement during sleep. 
Determination of accelerometer non-wear should be further explored in this population. It is 
possible that 120 minutes of zero counts is not sufficient and may result in removal of sedentary 
activity. 
 Variables such as employment status and participation in regular exercise programs 
should be examined in the context of fatigue and physical activity. Social factors such as 
employment, marital status and social activity should be incorporated into research studies to 
explore potential non-biologic causes for increased fatigue, especially in younger individuals. 
 Fatigue is known to persist beyond treatment in men receiving EBRT for prostate cancer 
(Feng et al., 2019). Measurement of physical activity at 6 months, 1 year or more after therapy 
will provide insight into long term consequences of fatigue. 
 Sleep disturbance correlated with fatigue at all time points. Sleep has been found to co-
occur with fatigue in breast cancer (Berger et al., 2019) and in men with prostate cancer treated 
with EBRT (Feng et al., 2019). In this population of men urinary symptoms are also found to be 
a contributing factor (Feng et al., 2019). Future research on the confluence of these symptoms 




 Causation in the relationship between fatigue and physical activity is not clear. It cannot 
be completely determined if fatigue is a limiting factor in activity or if increasing activity mitigates 
fatigue. While activity interventions have been shown to improve fatigue, many of these studies 
were done in breast cancer, with populations who may be younger and with fewer comorbid 
conditions. In a meta-analysis, physical activity had no significant effect on fatigue in colon cancer 
(Brandenbarg, Korsten, Berger & Berendsen, 2018). Hacker (2017) suggests that fatigue may be 
a limiting factor in physical activity and there might not be a two-way relationship in stem cell 
transplant recipients. The relationship between physical activity and fatigue should be further 
explored in different cancer populations. Timing and intensity of exercise interventions should be 
tailored to individuals based on cancer type and other factors. Since activity at completion is 
predictive of fatigue, adjustments in daily routine to allow for rest along with increased physical 
activity may be of benefit. Qualitative or mixed methods research in this area may be useful to 
determine the relationship between fatigue and activity. Through interviews or questionnaires, the 
idea of fatigue as a limiting factor of physical activity or of a sense of improvement in fatigue 
gained from exercise and/or increased daily physical activity could be explored.  
 This study found baseline fatigue, hemoglobin and sleep disturbance were predictive of 
fatigue at midpoint and completion of therapy in men receiving EBRT for prostate cancer. Physical 
activity at completion of therapy was predictive of fatigue. Interventions for fatigue may be 
targeted for this time. Given the lack of relationship between fatigue and physical activity during 
therapy, a variety of other factors, including social, emotional and daily patterns of activities 
should be explored. Patients, families and health professionals should be aware that fatigue is 
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